書籍詳細

I 消化器がん研究の基礎

P.8 掲載の参考文献

• 1) Segi, M. and Kurihara,M.:Cancer Mortality for Selected Sites in 24 Countries No.6(1966-1967), Japan Cancer Society, Tokyo, 1972.

• 2) WHO:World Health Statistics Annual, 1982-Vital Statistics and Causes of Death, Geneve, 1982.

• 3) 浜島信之, 青木國雄・他:日本人男性の悪性新生物部位別死亡の将来予測-日本癌学会第42回総会記事, 457, 1983.

P.23 掲載の参考文献

• 1) Waterhouse, J., Muir, C., Correa, P. et al.:Cancer incidence in five continents. Vol. III, IARC, Lyon, 1976.

• 2) Segi, M., Tominaga, S., Aoki, K. et al.:Cancer Mortality and morbidity statistics. Japan and the World. Gann Monograph 26, Japan Scientific Societies Press, Tokyo, 1981.

• 3) Huang, G. H.:Early detection and surgical treatment of esophageal carcinoma. Jpn. J. Surg. 11, 399-405, 1981.

• 4) 鍋谷欣市, 新井裕二:早期食道癌.診断と治療 66, 223-228, 1978.

• 5) 第28回食道疾患研究会記録:日消外会誌 13, 1205-1218, 1980.

• 6) 青木国雄, 岡田 啓, 佐々木隆一郎:食道癌の疫学.外科 Mook 24, 1-10, 1982.

• 7) McGlashan, N. D., Bradshaw, E. and Harington, J. S.:Cancer of the oesophagus and the use of tobacco and alcoholic beverages in Transkei, 1975-1976. Int. J. Cancer.29, 249-256, 1982.

• 8) Tuyns, A. J., Pequignot, G. and Abbatucci, J. S.:Oesophageal cancer and alcohol consumption. Int. J. Cancer.23, 443-447, 1979.
  pubmed

• 9) Weir, J. M. and Dunn, J. E.:Smoking and mortality:a prospective study. Cancer.25, 105, 1970.

• 10) Lyon, J. L, Gardner, J. W., Klauber, M. R. et al.:Low cancer incidence and mortality in Utah. Cancer.39, 2608-2618, 1977.
  pubmed

• 11) Phillips, R. L.:Role of life style and dietary habits in risk of cancer among Seventh Day Adventists. Cancer Res.35, 3513-3522, 1975.
  pubmed

• 12) Kuratsune, M., Kohchi, S. and Horie, A.:Carcinogenesis in the esophagus I. Penetration of benzo[a]pyrene and other hydrocarbons into the esophageal mucosa. Gann.56, 177-187, 1965.
  pubmed

• 13) Iizuka, T., Ichimura, S,, Kawachi, T. et al.:Carcinoma of the esophagus of rabbits induced with N-methylbenzylamine and sodium nitrite. Gann.68, 829-835, 1977.

• 14) Yang, C.S.:Research on esophageal cancer in China:a review. Cancer Res.40, 2633-2644, 1980.

• 15) Schalk, J. R.:Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer. JNCI.67, 243-251, 1981.

• 16) Burrell, R. J. W., Roach, W. A. and Shadwell, A.:Esophageal cancer in the Bantu of the Transkei associated with mineral deficiency in garden plants. JNCI.36, 201-209, 1966.

• 17) 笹野伸昭, 佐藤栄一, 河田武夫:食道癌, 太田邦夫, 山本 正, 杉村 隆:ヒトの癌と動物モデル, 南江堂, p.70-86, 1979.

• 18) Crespi, M., Munoz, N., Grassi, A. et al.:Oesophageal lesions in Northern Iran:a premalignant condition? Lancet. 217-220, 1979.
  pubmed

• 19) Munoz, N., Crespi, M., Grassi, A. et al.:Precursors lesions of oesophageal cancer in high-risk populations in Iran and China. Lancet, 876-879, 1982,
  pubmed

• 20) 飯塚紀文, 市村セツ子, 河内 卓, 徳永 昭:N-メチルベンジルアミンと亜硝酸ソーダによる実験食道癌.医学のあゆみ 88, 576-580, 1974より引用.

• 21) 井口 潔, 古沢元之助, 副島一彦, 三戸康郎, 阿部和哲, 池田俊彦, 川崎重義, 岡本龍治, 斉藤貴生:発育パターンからみた胃癌の予後.癌の臨床 14, 472-480, 1968.

• 22) Inokuchi, K., Kodama, Y., Sasaki, O., Kamegawa, T. and Okamura, T.:Differentiation of growth patterns of early gastric carcinoma determined by cytophotometric DNA analysis. Cancer. 51, 1138-1141, 1983.
  pubmed

P.31 掲載の参考文献

• 1) Sugimura, T. and Fujimura, S.. Tumour production in glandular stomach of rats by N-methyl-N'-nitro-N-nitrosoguanidine. Nature(London).216, 943-944, 1967.

• 2) Takahashi, M., Shirai, T., Fukushima, S. et al.:Effect of fundic ulcers induced by iodoacetamide on development of gastric tumors in rats treated with N-methyl-N'-nitro-N-nitrosoguanidine. Gann.67, 47-54, 1976.

• 3) Takahashi, M., Shirai, T., Fukushima, S. et al.:Ulcer formation and associated tumor production in multiple sites within stomach and duodenum of rats treated with N-methyl-N'-nitro-N-nitrosoguanidine. J. Natl. Cancer Inst.67, 473-479, 1981.

• 4) Takahashi, M., Fukushima, S. and Sato, H.:Carcinogenic effect of N-methyl-N'-nitro-N-nitrosoguanidine with various kinds of surfactant in the glandular stomach of rats. Gann.64, 211-218, 1973.

• 5) Kurihara, M., Shirakabe, H., Yamaya, F. et al.:Gastric carcinoma in dogs produced by the combined use of N-ethyl-N'-nitro-N-nitrosoguanidine(ENNG) and gastrin-with special reference to development of scirrhous carcinoma. Acta Pathol. Jpn.29, 171-176, 1979.

• 6) 高橋道人, 福島昭治, 花之内基夫:界面活性剤による発癌の促進.医学のあゆみ 88(13), 630-635, 1974.

• 7) Tatematsu, M., Katsuyama, T., Fukushima, S. et al.:Mucin histochemistry by paradoxical concanavalin A staining in experimental gastric cancers induced in Wistar rats by N-methyl-N'-nitro-N-nitrosoguanidine or 4-nitroquinoline 1-oxide. JNCI.64, 835-843, 1980.
  pubmed

• 8) Suganuma, T., Katsuyama, T., Tsukahara, M. et al.:Comparative histochemical study of alimentary tracts with special reference to the mucous neck cells of the stomach. Am. J. Anatomy.161, 219-238, 1981.

• 9) Furihata, C., Tatematsu, M., Shirai, T. et al.:Pepsinogens and stomach cancer, Pathophysiology of Carcinogenesis in Digestive Organs. E. Farber et al.(Eds) Univ. of Tokyo Press, Tokyo/Univ. Park Press, Baltimore, 49-63, 1977.

• 10) 高橋道人:消化器癌の発生と進展(2) 発癌とその修飾, 胃癌発生とその修飾.癌と化学療法10(2), 421-427, 1983.

• 11) Dahm, K. and Werner, B.:Susceptibility of the resected stomach to experimental carcinogenesis, Ztschr. Krebsforsch.85, 219-229, 1976.

• 12) Fukushima, S., Tatematsu, M. and Takahashi, M.:Combined effect of various surfactants on gastric carcinogenesis in rats treated with N-methyl-N'-nitro-N-nitrosoguanidine. Gann 65, 371-376, 1974.

• 13) 高橋道人, 小久保武, 黒川雄二・他:実験胃癌発生における高食塩食の影響について.目本癌学会総会記事 40, 73, 1981.

• 14) Fukushima, S., Hananouchi, M., Shirai, T. et al. :Effect of plastic bead on gastric carcinogenesis in rats treated with N'-methyl-nitro-N'-nitrosoguanidine. Gann.67, 197-205, 1976.

• 15) 三輪晃一, 高松 脩, 高島茂樹・他:迷走神経切断の胃癌に及ぼす影響.医学のあゆみ 88, 636-640, 1974.

• 16) Tatematsu, M., Takahashi, M., Fukushima, S. et al.:Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide, J. Natl. Cancer Inst.55, 101-106, 1975.
  pubmed

• 17) Takahashi, M., Kokubo, T., Furukawa, F. et al.:Effect of high salt diet on rat gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine. Gann.74, 28-34, 1983.

• 18) Kobori, O.:Analytical study of precancerous lesions in rat stomach mucosa induced by N-methyl-N'-nitro-N-nitrosoguanidine. Gann Monogr. Cancer Res, 25, 141-150, 1980.

• 19) Matsukura, N, Kawachi, T., Sano, T. et al.:Promoting action of croton oil on gastrocarcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in rats.J. Cancer Res. Clin. Oncol.93, 323-327, 1979.

• 20) Kogure, K., Sasadaira, H., Kawachi, T. et al.:Further studies on induction of stomach cancer in hamstars by N-methyl-N'-nitro-N-nitrosoguanidine. Br. J. Cancer.29, 132-142, 1974.

• 21) Sugimura, T., Fujimura, S., Kogure, K. et al.:Production of adenocarcinomas in the glandular stomach of experimental animals by N-methyl-N'-nitro-N-nitrosoguanidine. Gann Monogr.8, 157-196, 1969.

• 22) Bralow, S. P., Gruenstein, M. and Meranze, D. R.:Strain resistance to gastric adenocarcinoma in rats ingesting NG. Proc. Am. Assoc. Cancer Res.12, 3, 1971.

• 23) Martin, M. S., Martin, F., Justrabo, E. et al.:Susceptibility of inbred rats to gastric and duodenal carcinomas induced by N-methyl-N'-nitro-N-nitrosoguanidine. J. Natl. Cancer Inst.53, 837-840, 1974.

• 24) Ohgaki, H., Kawachi, T., Matsukura, N. et al.:Genetic control of susceptibility of rats to gastric carcinoma. Cancer Res.43, 3663-3667, 1983.
  pubmed

• 25) Furukawa, H., Iwanaga, T., Koyama, H. et al.:Effect of sex hormones on the experimental induction of cancer in rat stomach.-A preliminary study. Digestion.23, 151-155, 1982.
  pubmed

• 26) Kimura, M., Fukuda, T, and Sato, K.:Effect of aging on the development of gastric cancer in rats induced by N-methyl-N'-nitro-N-nitrosoguanidine. Gann.70, 521-525, 1979.

• 27) Tahara, E. and Haizuka, S.:Effect of gastro-entero-pancreatic endocrine hormones on the histogenesis of gastric cancer in rats induced by N-methyl-N'-nitro-N-nitrosoguanidine;with special reference to development of scirrhous gastric cancer Gann.66, 421-426, 1975.

• 28) Tahara, E., Shimamoto, F., Taniyama, K. et al.:Enhanced effect of gastrin on rat stomach carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine. Cancer Res.42, 1781-1787, 1982.

• 29) Tatsuta, M., Itoh, T., Okuda, S. et al.:Effect of prolonged administration of gastrin on experimental carcinogenesis in rat stomach induced by N-methyl-N'-nitro-N-nitrosoguanidine. Cancer Res.37, 1808-1810, 1977.

• 30) Tatsuta, M., Yamamura, H., Ichii, M. et al.:Promotion by histamine of carcinogenesis in the forestomach and protection by histamine against carcinogenesis induced by N-nitroso-N-methylnitroguanidine in the glandular stomach in W rats, JNCI.71, 361-365, 1983.

• 31) Kurihara, M., Shirakabe, H., Murakami, T. et al.:A new method for producing adenocarcinomas in the stomach of dogs with N-ethyl-N'-nitro-N-nitrosoguanidine. Gann.65, 163-177, 1974.

• 32) Fujita, M., Takami, M., Usugane, M. et al.:Enhancement of gastric carcinogenesis in dogs given N-methyl-N'-nitro-N-nitrosoguanidine following vagotomy. Cancer Res.39, 811-816, 1979.

P.41 掲載の参考文献

• 1) Lorenz, E. G. and Stewart, H. L.:Intestinal carcinoma and other lesions in mice following oral administration of 1, 2, 5, 6-dibenzanthracene and 20-methylcholanthrene. J. Natl, Cancer. Inst. 1, 17-40, 1941-1942.

• 2) Walpole, A. L, Williams, M. and Roberts, D. C.:The carcinogenic action of 4-aminodiphenyl and 3:2'-dimethyl-4-aminodiphenyl. Br. J. Ind. Med.9, 255-263, 1952.

• 3) Laqueur, G. L, Mickelson, O., Whiting, M. G. et al.:Carcinogenic properties of nuts from cycas circinalis L. indigenous to Guam. J. Natl. Cancer. Inst.31, 919-951, 1963.

• 4) Druckrey, H., Preussmann, R., Matzkies, F. et al.:Selektive Erzeugung von Darmkrebs bei Ratten durch 1,2-dimethyl-hydrazin. Naturwissenschaften.54, 285-286, 1967.
  pubmed

• 5) Narisawa, T., Sato, T., Hayakawa, M. et al.:Carcinoma of the colon and rectum of rats by rectal infusion of N-methyl-N'-nitro-N-nitrosoguanidine. Gann.62, 231-234, 1971.

• 6) Druckrey, H., Preussmann, R., Ivankovic, S. et al.:Zur Erzeugung subcutaner Sarkome an Rattan. Z. Krebsforsch.68, 87-102, 1966.

• 7) Newberne, P. M. and Rogers, A.:Rat colon carcinomas associated with aflatoxin and marginal vitamin A. J. Natl. Cancer. Inst.50, 439-448, 1973.
  pubmed

• 8) Ward, J. M., Yamamoto, R. S. and Brown, C. A.:Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane. J, Natl. Cancer. Inst.51,1029-1039, 1973.

• 9) Fiala, E. S.:Investigations into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine. Cancer.36, 2407-2412, 1975.

• 10) Laquer, G. L:Carcinogenic effects of cycad meal and cycasin, methylazoxymethanol glycoside, in rats and effects of cycasin in germfree rats. Fed. Proc.23, 1386-1387, 1964.

• 11) Campbell, R. L., Singh, D. V. and Nigro, N. D.:Importance of the fecal stream on the induction of colon tumors by azoxymethane in rats. Cancer Res.35, 1369-1371, 1975.
  pubmed

• 12) Shimizu, H. and Toth, B.:Autoradiographic studies on the distribution of 14C-1,2-dimethylhydrazine dihydrochloride and its effects on DNA synthesis in Swiss mice. Gann.66, 589-601, 1975.
  pubmed

• 13) Pozharisski, K. M., Kapustin, Y. M., Likhachev, A. J. et al.:The mechanism of carcinogenic action of 1,2-dimethylhydrazine(SDMH) in rats. Int. J. Cancer.15, 673-683, 1975.
  pubmed

• 14) Margison, G. B. and Kleihues, P.:Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain DNA during repetitive administration of N-methyl-N-nitrosourea. Biochem. J.148, 521-525, 1975.

• 15) Rogers, K. J. and Pegg, A. E.:Formation of O6-methylguanine by alkylation of rat liver, colon and kidney DNA following administration of 1,2-dimethylhydrazine. Cancer Res.37, 4082-4087, 1977.
  pubmed

• 16) Gennaro, A. R., Villanueva, R., Sukonthaman,Y. et al.:Chemical carcinogenesis in transposed intestinal segments. Cancer Res.33, 536-541, 1973.
  pubmed

• 17) Celik, C., Mittelman, A., Paolini, N. S. et al:Effects of 1,2-symmetrical dimethylhydrazine on jejunocolic transposition in sprague-Dawley rats. Cancer Res.41, 2908-2911, 1981.
  pubmed

• 18) Kanagalingam, K. and Balis, E. M.:In vivo repair of rat intestinal DNA damage by alkylating agents. Cancer.36, 2364-2372, 1975.

• 19) Wynder, E. L, Kajitani, T., Ishikawa, S. et al.:Environmental factors of cancer of the colon and rectum II. Japanese epidemiological data. Cancer.23, 1210-1220, 1969.
  pubmed

• 20) Haenszel, W. and Kurihara, M:Studies of Japanese migrants.1. Mortality from cancer and other chronic diseases among Japanese in the United States. J. Natl. Cancer. Inst.40, 43-68, 1968.

• 21) Hill, M. J. and Aries, V. C.:Fecal steroid composition and its relationship to cancer of the large bowel. J. Pathol. Bact.104, 129-139, 1971.

• 22) Reddy, B. S. and Wynder, E. L:Large bowel carcinogenesis:fecal constituents of populations with diverse incidence rates of colon cancer. J. Natl. Cancer. Inst.50, 1437-1442, 1973.
  pubmed

• 23) Cook, J. W. and Haslewood, G. A.:Conversion of a bile acid into a hydrocarbon derived from 1,2-benzanthracene. Chem. Indust, 11, 758-759, 1933.

• 24) Nigro, N. D., Bhadrachari, N. and Chomchai, C.:A rat model for studing colonic cancer. Effect of cholestyramine on induced tumors. Dis Colon Rectum.16, 438-443, 1973.

• 25) Chomchai, C., Bhadrachari, N. and Nigro, N. D, :The effect of bile on the induction of experimental intestinal tumors in rats. Dis Colon Rectum.17, 310-312, 1974.
  pubmed

• 26) Koga, S., Kaibara, N. and Takeda, R.:Effect of bile acids on 1,2-dimethylhydrazine-induced colon cancer in rats. Cancer.50, 543-547, 1982.
  pubmed

• 27) Narasawa, T., Magadia, N. E., Weisburger, J. H. et at.:Promoting effects of bile acids on colon carcinogenesis after intrarectal installation of N-methyl-N'-nitro-N-nitrosaguanidine in rats. J. Natl. Cancer Inst.53, 1093-1097, 1974.

• 28) Cohen, B.I., Raicht, R. F., Deschner, E. E. et al.:Effect of cholic acid feeding on N-methyl-N-nitrosourea-induced colon tumors and cell kinetics in rats. J. Natl. cancer Inst.64, 573-578, 1980.

• 29) Nigro, N.D., Singh, D.V., Campbell, R. L. et al.:Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats. J. Natl. Cancer Inst.54, 439-442, 1975.
  pubmed

• 30) Reddy, B. S., Weisburger, J. H. and Wynder, E. L.:Effects of dietary fat level and dimethylhydrazine on fecal acid and neutral sterol excretion and colon carcinogenesis in rats. J. Natl, Cancer Inst.52, 507-511, 1974.
  pubmed

• 31) Goldin, B. R, and Gorbach, S. L.:The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J. Natl. Cancer Inst.57, 371-375, 1976.
  pubmed

• 32) Reddy, B. V., Mangat, S., Weisburger, J. H. et al.:Effect of high risk diets for colon carcinogenesis on intestinal mucosal and bacterialβ-glucuronidase activity in F 344 rats. Cancer Res. 37, 3533-3536, 1977.

• 33) Takada, H., Hirooka, T., Hiramatsu, Y. et al.:Effect of β-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res.42, 331-334, 1982.

• 34) Paymaster, J. C., Sanghvi, L. D. and Gangodharan, P.:Cancer in the gastrointestinal tract in Western India. Cancer(Phila.) 21, 279-288, 1968.

• 35) Burkitt, D. P, :Epidemiology of cancer of the colon and rectum. Cancer.28, 3-13, 1971.
  pubmed

• 36) Ward, H. M., Yamamoto, R. S. and Weisburger, J. H.:Cellulose dietary bulk and azoxymethane-induced intestinal cancer. J. Natl. Cancer Inst.51, 713-715, 1973.

• 37) Freeman, H. J., Spiller, G. A. and Kim, Y. S.:A double-blind study on the effect of purified cellulose dietary fiber on 1,2-dimethylhydrazine-induced rat colonic neoplasia. Cancer Res.38, 2912-2917, 1978.

• 38) Barbolt, T. A. and Abraham, R.:The effect of bran in dimethylhydrazine-induced colon carcinogenesis in the rat. Proc. Soc. Exp. Biol. Med.157, 656-659, 1978.
  pubmed

• 39) Fieiszer, D., MacFarlane, J., Murray, D. and Brown, R. A.:Protective effect of dietary fibre against chemically induced bowel tumors in rats. Lancet.2, 552-553, 1978.

• 40) Watanabe, K, Reddy, B. S., Weisburger, J. H. and Kritchevsky, D.:Effect of dietary alfalfa, pectin, and wheat bran on azoxymethane or methylnitrosourea-induced colon carcinogenesis in F 344 rats. J. Natl. Cancer Inst.63, 141-145, 1979.
  pubmed

• 41) Druckrey, H.:Production of colonic carcinomas by 1,2-dialkylhydrazines and azoxyalkanes. In Carcinoma of the Colon and Antecedent Epithelium. Edited by W.J. Burdette, Springfield., C.C. Thomas, p.267-279, 1970.

• 42) Thurnherr, N., Deschner, E., Stonehill, E. et al.:Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res.33, 940-945, 1973.

• 43) Ward, J. M., Yamamoto, R. S., Benjamin, T. et al.:Experimentally induced cancer of the colon in rats and mice. J. Am. Vet. Med. Assoc.164, 729-732, 1974.
  pubmed

• 44) Sigdestad, C. P., Bauman, J. and Lesher, S, W.:Diurnal fluctuations in the number of cells in mitosis and DNA synthesis in the jejunum of the mouse. Exp Cell Res.58, 159-162, 1969.
  pubmed

• 45) Al-Dewachi, H. S., Wright, N. A., Appleton, D. R. et al.:Studies on the mechanism of diurnal variation of proliferative indices in the small bowel mucosa of the rat. Cell Tissue Kinet.9, 459-467, 1976.
  pubmed

• 46) Barthold, S. W.and Beck, D.:Modification or early dimethylhydrazine carcinogenesis by colonicmucosal hyperplasia. Cancer Res.40, 4451-4455, 1980.
  pubmed

• 47) 吉川宣輝, 安富正幸・他:大腸腫瘍の発生に関する研究. 胃と腸 8(11), 1519-1527, 1973.

• 48) 吉川宣輝, 安富正幸:大腸ポリープの増殖を隆起. 胃と腸 10(3), 391-397, 1975.

• 49) Kritchevsky, D.:Fiber, steroids and cancer. Cancer Res(Suppl.).43, 2491-2495, 1983.

P.52 掲載の参考文献

• 1) Nicolson, G. L:Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim. Biophys. Acta.695, 113-176, 1982.
  pubmed

• 2) Kleinermann, J. and Liotta, L A.:Release of tumor cells. Cancer Invasion and Metastasis:Biologic mechanisms and therapy, edited by Day SB et al. Raven Press, New York, pp.135-143, 1977.

• 3) Gullino, P. M.:Angiogenesis and neoplasia. New Eng. J. Med.305, 884-885, 1981.
  pubmed

• 4) Folkman, J.:Angiogenesis:Inhibition and control. Ann. N. Y. Acad Sci.401, 212-227, 1982.

• 5) Folkman, J.:Tumor angiogenesis. Adv. Cancer Res.19, 331-358, 1974.

• 6) Folkman, J.:Tumor angiogenesis factor. Cancer Res.34, 2109-2113, 1974.
  pubmed

• 7) Wirl, G.:Collagenase activity in an animal and a human carcinoma. Wien Klin Wochenschr. 89, 766-768, 1977.

• 8) Liotta, L. A., Tryggvasson, K., Garbisa, S. et al.:Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature(Lond). 284, 67-68, 1980.

• 9) Sloane, B. F.. Dunn, J. R. and Honn, K. V.:Lysosomal cathepsin B:Correlation with metastatic potential Science.212, 1151-1153, 1981.
  pubmed

• 10) 田中健蔵:癌と凝固線溶-とくに線溶阻止による癌の増殖. 転移の抑制-. 癌の臨床 26, 117-122, 1980.

• 11) Liotta, L. A., Goldfarb, R. H., Brundage, R. et al.:Effect of plasminogen activator(urokinase), Plasmin, and thrombin on glycoprotein and collageneous components of basement membrane. Cancer Res.41, 4629-4636, 1981.
  pubmed

• 12) Koono, J., Ushijima, K. and Hayashi, H.:Studies on the mechanisms of invasion in cancer. III. Purification of a neutral protease of rat ascites hepatoma cell associated with production of chemostactic factor for cancer cells. Int. J. Cancer.13, 105-115, 1974.

• 13) Salo, T., Liotta, L. A., Keski-Oja, J. et al.:Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells-role in metastasis. Int. J. Cancer.30, 669-673, 1982.
  pubmed

• 14) Nakajima, M., Irimura, T., Ferrante, D. D. et al.:Heparan sulfate degradation:Relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science.220, 611-613, 1983.

• 15) Pietras, R. J., Szego, C. M., Mangan, C. E. et al.:Elevated serum cathepsin B1-like activity in women with neoplastic disease. Gynecol Oncol.7, 1-17, 1979.
  pubmed

• 16) 田中健蔵:X.癌と凝固・線溶. 日本癌治療学会誌 15, 71-73, 1980.

• 17) Kinjo, M., Oka, K., Naito, S. et al.:Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br. J. Cancer.39, 15-23, 1979.
  pubmed

• 18) Hanna, N. and Fidler, I. J.:Role of natural killer cells in the destruction of circulating tumor emboli, J. Natl. Cancer Inst.65, 801-809, 1980.
  pubmed

• 19) Fidler, I. J.:General considerations for studies of experimental cancer metastasis. Methods Cancer Res.15, 399-439, 1978.

• 20) Kinjo, M.:Lodgement and extravasation of tumor cells in blood-borne metastasis:an electron microscope study. Br. J. Cancer.38, 293-301, 1978.
  pubmed

• 21) Zeidman, I.:The fate of circulating tumor cells:I. Passage of cells through capillaries. Cancer Res.21, 38-39, 1961.
  pubmed

• 22) Warren, B. A.:Origin and fate of blood-borne tumor emboli. Cancer Biol Rev.2, 95-169, 1981.

• 23) Grignani, G., Almasio, P., Pacchiarini, L. et al:Interactions between neoplastic cells with different metastasizing capacity and platelet function. Eur. J. Clin. Oncol.19, 519-525, 1983.

• 24) Warren, B. A., Chauvin, W. J. and Philips, J.:Blood-borne tumor emboli and their adherence to vessel walls. Cancer Invasion and Metastasis:Biologic mechanisms and therapy, edited by Day SB et al. Raven Press, New York, pp.185-198, 1977.

• 25) Nicolson, G. L. and Winkelhake, J. L.:Organ specificity of blood-borne tumour metastasis determined by cell adhesion? Nature.255, 230-232, 1975.
  pubmed

• 26) Varani, J., Lovett III, E. J., McCoy Jr, J. P. et al:Differentiated expression of a lamininlike substance by high-and low-metastatic tumor cells. Am. J. Pathol.111, 27-34, 1983.

• 27) Hagmar, B. and Norrby, K.:Influence of cultivation, trypsinization and aggregation on the transplantability of melanoma B16 cells. Int. J. Cancer.209, 157-159, 1973.

• 28) Sinba, B. K. and Goldenberg, G. J.:The effect of trypsin and neuraminidase on the circulation and organ distribution of tumor cells. Cancer.34, 1956-1961, 1974.

• 29) Irimura, T., Gonzalez, R. and Nicolson, G. L:Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties. Cancer Res.41, 3411-3418, 1981.
  pubmed

• 30) Poste, G, and Nicolson, G. L.:Arrest and metastasis of a blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc. Natl. Acad. Sci. USA. 77, 399-403, 1980.
  pubmed

• 31) Tao, T-W. and Johnson, L. K.:Altered adhessiveness of tumor cell surface variants with reduced metastasizing capacity-reduced adhessiveness to vascular components in culture. Int. J. Cancer.30, 763-766, 1982.
  pubmed

• 32) Tao, T-W. and Burger, M, M.:Non-metastasizing variants selected from metastasizing melanoma cells, Nature.270, 437-438, 1977.
  pubmed

• 33) Tao, T-W. and Burger, M. M.:Lectin-resistant variants of mouse melanoma cells.I. Altered metastasizing capacity and tumorigenicity. Int. J. Cancer.29, 425-430, 1982.
  pubmed

• 34) Ambrus, J. L, Ambrus, C. M., Gastpar, H. et al.:Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis. J. Med. 13, 35-47, 1982.
  pubmed

• 35) Hara, Y., Steiner, M. and Baldini, M. G.:Characterization of platelet-aggregating activity of tumor cells. Cancer Res.40, 1217-1221, 1980.
  pubmed

• 36) Lerner, W. A., Pearlstein, E., Ambrogio, C. et al.:A new mechanism for tumor-induced platelet aggregation. Comparison with mechanisms shared by other tumors with possible pharmacologic strategy toward prevention of metastases. Int. J. Cancer.31, 463-469, 1983.
  pubmed

• 37) Kohga, S., Kinjo, M., Tanaka, K. et al.:Effects of 5-(2-chlorobenzyl) -4, 5, 6, 3-tetrahydrothieno(3,2-C) pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor on blood-borne metastasis. Cancer Res.41, 4710-4714, 1981.
  pubmed

• 38) Gasic, G., Gasic, T. and Stewart, C. C.:Antimetastatic effects associated with platelet reduction. Proc. Natl. Acad. Sci.(USA). 61, 46-52, 1968.
  pubmed

• 39) Honn, K. V., Cicone, B. and Skoff, A.:Prostacyclin:A potent antimetastatic agent. Science. 212, 1270-1272, 1981.
  pubmed

• 40) Sato, H. and Suzuki, M.:Deformability and viability of tumor cells by transcapillary passage, with reference to organ affnity of metastasis in cancer. Fundamental Aspects of Metastasis, edited by Weiss L, North-Holland Publishin Co., Amsterdam, pp.311-317, 1976.

• 41) Hart, I. R., Raz, A. and Fidler, I. J.:Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells. J. Natl. Cancer Inst.64, 891-899, 1980.

• 42) Shearman, P. J. and Longenecker, B. M.:Clonal variation and functional correlation of organspecific metastasis and an organ-specific metastasis associated antigen. Int. J. Cancer.27, 387-395, 1981.

• 43) Shearman, P. J., Gallatin, W. M. and Longenecker, B. M.:Detection of a cell.surface antigencorrelated with organ specific metastasis. Nature.286, 267-269, 1980.
  pubmed

• 44) Nachman, R. L, Weksler, B. and Ferris, B.:Characterization of human platelet vascular permiability-enhancing activity. J. Clin. Invest.51, 549-556, 1972.

• 45) Hart, I. R. and Fidler, L. J.:An in vitro quantitative assay for tumor cell invasion, Cancer Res.38, 3218-3224, 1978.

• 46) Sunkara, P. S., Prakash, N. J. and Rosenberger, A. L:An essential role for polyamines intumor metastases. FEBS Letters.150, 397-399, 1983.

• 47) Kohga, S. and Tanaka, K.:Role of tumor thromboplastin in the mode of distribution of metastatic foci in the lung. Gann.70, 615-619, 1979.

• 48) 田中健蔵, 福本純雄:腫瘍血管の特性とその癌治療における意義. 癌と化学療法 10, 1564-1568, 1983.
  Medical*Online

• 49) Fisher, B., Fisher, E. R. and Fedska, N.:Trauma and the localization of tumor cells. Cancer.20, 23-30, 1967.

• 50) Kuettner, K. E., Soble, L, Croxen, I. J. et al.:Tumor cell collgenase and its inhibition by a cartilage derived protease inhibitor. Science.196, 653-654, 1977.

• 51) Cochran, A. J.:Malignant melanoma:A review of 10 years'experience in Glasgow, Scotland.Cancer. 23, 1190-1199, 1973.

• 52) Proctor, J. W., Auclair, B. G. and Stokowski, L:Endocrine factors and the growth and spread of B16 melanoma. J. Natl. Cancer Inst.57, 1197-1198, 1976.
  pubmed

• 53) Kollmorgen, G. M., King, M. M., Kosanke, S. D. et al.:Influence of dietary fat and indomethacin on the growth of transplantable mammary tumors in rats. Cancer Res.43, 4714-4719, 1983.
  pubmed

• 54) Sakai, T., Yamaguchi, N, Kawai, K. et al.:Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells. Cancer Letters.17, 289-294, 1983.
  pubmed

• 55) Fukushima, M., Kato, T., Ueda, R. et al.:Prostaglandin D2 a potential antineoplastic agent.Biochem. Biophys. Res. Commun.105, 956-964, 1982.
  pubmed

• 56) Gorelik, E., Segal, S. and Feldman, M.:Growth of local tumor exerts a specific inhibitory effect on progression of lung metastasis. Int. J. Cancer.21, 617-625, 1979.

• 57) Fidler, I. J.:Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res, 38, 2651-2660, 1978.
  pubmed

• 58) Poste, G.:Experimental systems for analysis of the malignant phenotype. Cancer Metastasis Rev. 1, 141-199, 1982.
  pubmed

• 59) Hart, I. R. and Fidler, I. J.:The implications of heterogeneity for studies on the biology and therapy of cancer metastasis. Biochim. Biophys. Acta. 651, 37-50, 1981.

• 60) Tao, T. W., Jenkins, J. M., Vosbeck, K. et al.:Lectin.resistant variants of mouse melanoma cells. II, in vitro characteristics. Int. J. Cancer.31, 239-247, 1983.

• 61) Liotta, L. A., Rao, C. N. and Barsky, S. H.:Tumor invasion and the extracellular matrix.Lav. Invest.49, 636-649, 1983.

• 62) Terranova, V. P., Liotta, L. A., Russo, R. G. et al.:Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res.42, 2265-2269, 1982.
  pubmed

• 63) Kodama, Y. and Tanaka, K.:Thromboplastic and fibrinolytic activities of V2 and V7 carcinomas of rabbit, with special reference to fibrin deposition and thrombus formation in the tumors. Acta. Pathol. Jap.28, 279-286, 1978.

• 64) Bruesch, M. R., Johnson, G. L, Palackdharry, C. S. et al.:Plasminogen activator in normal and tumor-bearing mice. Int. J. Cancer.32, 121-126, 1983.
  pubmed

• 65) Werb, Z., Burleigh, M. C., Barrett, A. J. et al.:The interactions of a2-macro-globulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases. Biochem. J.139, 359-368, 1974.

• 66) Wooley, D. E., Roberts, D. R. and Evanson, J. M.:Small molecular weight β1 serum protein which specifically inhibits human collagenases. Nature, 261, 325-327, 1976.

• 67) Thorgeirsson, U. P., Liotta, L A., Kalebic, T. et al.:Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J. Natl. Cancer Inst.69, 1049-1054, 1982.

• 68) Holme, R., Oftebro, R. and Hovig, T.:In vitro interaction between cultured cells and human platelets. Thromb Haemostasis, Stuttg.40, 89-102, 1978.

• 69) 田中健蔵, 福本純雄:腫瘍の血行性転移における血小板とプロスタグランディンの意義. 癌と化学療法 10, 1944-1947, 1983.
  Medical*Online

• 70) Langer, R., Brem, H., Falterman, K. et al.:Isolation of a cartilage factor that inhibits tumor neovasculization. Science.193, 70-72, 1976.

• 71) Sundbeck, A., Myrhage, R. and Peterson, H, I.:Influence of tranexamic acid on tumor vasculization. An experimental microangiographic study. Anti Cancer Res.1, 295-298, 1981.

• 72) 田中健蔵:がんと線溶. 癌と化学療法 2, 545-557, 1980.

• 73) Folkman, J.:Protamine is an inhibitor of angiogenesis. Nature.297, 307-312, 1982.
  pubmed

P.64 掲載の参考文献

• 1) 菅野晴夫, 中村恭一, 高木国夫・他:異なった2つの胃癌の提唱-病理学の立場から.医学のあゆみ 71, 641-643, 1969.

• 2) 中村恭一:胃癌の病理, 微小癌と組織発生.金芳堂.京都, 1972.

• 3) Lauren, P.:The two histological main types of gastric carcinoma:diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Path. et Microbiol. Scandinav.64, 31-49, 1965.

• 4) Sugano, H., Nakamura, K. and Kato, Y.:Pathological studies of human gastric cancer. Acta Pathol. Jpn.32 (Suppl.2), 329-347, 1982.

• 5) Kawachi, T., Kogure, K., Tanaka, N. et al.:Studies of intestinal metaplasia in the gastric mucosa by detection of disaccharases with"Tes-Tape."J. Nat. Cancer Inst.53, 19-30, 1974.

• 6) 松倉則夫, 河内 卓:胃癌発生と腸上皮化生.最新医学 34, 453-456, 1979.
  Medical*Online

• 7) 吉田 均, 広田映五, 板橋正幸・他:小胃癌の背景粘膜-腸上皮化生粘膜, とくに不完全型との関係, Progress of Digestive Endoscopy.17, 120-124, 1980.

• 8) 加藤 洋, 菅野晴夫:胃および大腸の前癌病変, 病理学の立場から.癌と化学療法 10, (2) 443-458, 1983.
  Medical*Online

• 9) Kurihara, M.:National Mortality and incidence in Japan. Environmental Health Perspectives. 32, 59-74, 1979.
  pubmed

• 10) 加藤 洋, 中村恭一, 北川知行, 菅野晴夫:胃癌組織型の時代的推移-1955-1974年の切除胃癌症例の分析-.胃と腸 15, 19-25, 1980.

• 11) Hanai, A., Fujimoto, I. and Taniguchi, H.:Trends of stomach cancer incidence and histological types in Osaka. pp.143-154, In Trends in Cancer Incidence Ed. K. Magnus. Hemisphere Publ. Corp. Washington, 1982.

• 12) Antonioli, D. A. and Cady, B.:Changing aspects of gastric adenocarcinoma. New Engl. J. Med.310(24), 1538, 1984.

• 13) Nakamura, K., Sugano, H., Takagi, K. et al.:Histopathological study on early carcinoma of the stomach:Criteria for diagnosis of atypical epithelium. Gann.57, 613-620, 1966.

• 14) Sugano, H., Nakamura, K. and Takagi, K.:An atypical epithelium of the stomach. A clinicopathological entity, Gann Monograph on Cancer Res.11, 257-269, 1971.

• 15) 加藤 洋, 柳沢昭夫, 菅野晴夫:胃の良性悪性境界領域病変. 最新医学 36, 21-30, 1981.

• 16) 高木国夫:胃の早期癌と境界病変の自然史, 癌と化学療法 7 第38回1.1本癌学会総会特集号, 3-15, 1980.

• 17) Morson, B. C., Sobin, L. H., Grundmann, E. et al.:Precancerous conditions and epithelial dysplasia in the stomach. J. Clin. Path.33, 711-721, 1980.
  pubmed

• 18) 加藤 洋, 菅野晴夫, 北川知行・他:多発胃癌の解析による微小胃癌の進展.第69回日病総会, 1980.

• 19) 菅野晴夫:ヒト癌の自然史, 日病会誌 69, 27-57, 1980.

• 20) Inokuchi, K., Inutsuka, S., Furusawa, M. et al.:Clinico-pathological features of the superficial spreading carcinoma in comparison with the usual penetrating carcinoma of the stomach. Recent advances in gastroenterology, The Proceedings of the 3rd World Congress of Gastroenterology, Vol.I, pp.536-538, 1967.

• 21) 佐々木 攻, 亀川隆久, 児玉好史, 井口 潔:細胞核DNA量分布パターン分析によるSuper型およびPen型表在胃癌の臨床的考察. 医学のあゆみ 117(8), 425-428, 1981.

• 22) 佐藤博:昭和56年度全国集計.消化器集検60, 46-58, 1983.

• 23) 藤井 彰, 淵上在弥, 大城宏之・他:胃集検受診者の追跡と発見胃癌.消化器集検 62, 94-101, 1984.

• 24) Wintrobe, M. M.:Clinical Hematology(VIII ed.). Lea & Febiger, Philadelphia, 1981, p 1693.

• 25) Stalsberg, H. and Taksdal, S.:Stomach cancer following gastric surgery for benign conditions. The Lancet.7718, 1175-1177, 1971.

• 26) 近藤 建, 鈴木春見, 長与健夫・他:残胃癌の病理. 癌の臨床 28(14), 1615-1623, 1982.

• 27) 北岡久三, 吉田茂昭, 大倉久直・他:胃スキルスの内分泌化学療法. 代謝 20, 臨時増刊号"癌'83", 237-248, 1983.

• 28) 堀 雅晴, 高木国夫・他:胃癌のエストロゲンレセプター, プロゲステロンレセプターについて. 第21回癌治療学会, 1983.

• 29) 加藤 洋, 菅野晴夫, 和田潤一・他:大腸癌の病理, pp.39-58, 内科シリーズ, No.30, 大腸癌のすべて. 常岡健二編, 南江堂, 東京, 京都, 1978.

• 30) 渡辺英伸. 私信.

• 31) 癌研究会附属病院外科業績集,1982.

• 32) 加藤 洋, 菅野晴夫, 北川知行・他:大腸癌切除標本における静脈内癌侵襲(v+) の意義, 第38回目本癌学会総会, 1979.

• 33) 岩間毅夫, 宇都宮譲二. 私信.

• 34) 武藤徹一郎:大腸ポリープ-その病理と臨床. 南江堂, 東京, 1979.

• 35) 柳沢昭夫, 加藤 洋, 菅野晴夫:大腸癌の発生-腺腫の明調細胞型・暗調細胞型との関係, 医学のあゆみ 122, 428-435, 1982.

• 36) 藤原 章, 柳沢昭夫, 加藤 洋・他:家族性大腸腺腫症と非家族性大腸腺腫症における腺腫の癌合併率の比較, 第21回大腸癌研究会, 1984.

• 37) Utsunomiya, J., Murata, M. and Tanimura, M.:An analysis on the age distribution of colon cancer in adenomatosis coli. Cancer.45, 198-205, 1980.
  pubmed

• 38) Miyaki, M., Akamatsu, N., Ono, T. et al.:Morphologic transformation and chromosomal changes induced by chemical carcinogens in skin fibroblasts from patients with familial adenomatosis coli. J. Nat. Cancer Inst.68, 563-571, 1982.

• 39) Miyaki, M., Suzuki, K., Mori, H. et al.:Changes in DNA synthesis induced by MNNG, MMS and UV light. The 5th Radiation Biology Cancer International Symposium:DNA Repair and Chemical Damages, Nov.11-14, 1982.

• 40) 柳沢昭夫, 加藤 洋, 菅野晴夫:前癌病変としての大腸腺腫.臨床成人病 11, 1889-1895, 1981.

• 41) 加藤 洋・他:大腸腺腫の発生点. 第65回日本病理学会, 1976.

• 42) Bussey, H. J. R. Familial polyposis coli Johns Hopkins Univ. Press, Baltimore, 1975.

• 43) Lynch, H. T. and Krush, A. J.:Heredity and adenocarcinoma of the colon. Gastroenterology. 53, 517-527, 1967.
  pubmed

• 44) Culling, C. F. A., Reid, P. E. and Dunn, W. L:A new histochemical method for the identification and visualization of both side chain acylated and nonacylated sialic acids. J. Histochem. Cytochem.24, 1225-1230, 1976.

• 45) Yonezawa, S. et al.:Glycoconjugate with ulex europaeus agglutinin-1-binding sites in normal mucosa, adenoma, and carcinoma of the huma large bowel. JNCI.69, 777-781, 1982.

• 46) 四本紘一:大腸粘液細胞の粘液組織化学的研究-とくに大腸癌との関連性.医学研究 54(3), 337-350, 1984.

• 47) Filipe, M.I. and Branfoot, A. C.:Abnormal patterns of mucus secretion in apprently normal mucosa of large intestine with carcinoma, Cancer.34, 282-290, 1974.

• 48) 柳沢昭夫, 加藤 洋, 藤原 章:放射線大腸炎粘膜における粘液性状の変化-Blue ctyptの出現頻度(Blue crypt index) について.目病会誌(総会号), 1984.

P.75 掲載の参考文献

• 1) Nakamura, K., Sugano, H., Takagi, K. and Fuchigami, A.:Histopathological study on early carcinoma of the stomach:Criteria for diagnosis of atypical epithelium. GANN 57, 613-620, 1966.

• 2) 高木国夫, 菅野晴夫, 中村恭一, 熊倉賢二:胃の異型上皮巣の臨床病理学的研究. 癌の臨床 17, 905-914, 1971.

• 3) 遠藤次彦, 中村恭一, 菅野晴夫;胃の異型上皮巣と分化型癌の病理組織学的比較. 胃の臨床 21, 1242-1253, 1975.

• 4) Sugano, H., Nakamura, K. and Takagi, K.:An atypical epithelium of the stomach. A clinicopathological entity. GANN Monograph on Cancer Res.11, 257-269, 1971.

• 5) 中村恭一:胃癌の病理, 微小癌と組織発生. 金芳堂. 京都, 1972.

• 6) 加藤 洋, 柳沢昭夫, 菅野晴夫:胃の良性悪性境界領域病変. 最新医学 36, 21-30, 1981.

• 7) 中村恭一, 菅野晴夫, 高木国夫, 熊倉賢二:胃の異型上皮巣の組織発生-微小異型上皮巣を中心とした光顕的ならびに電顕的研究.癌の臨床 15, 955-969, 1969.

• 8) Konjetzny, G. E.:Die Entztindung des Magens. In:Henke, F. u. Lubarsch, O:Handbuch d.spez. path. Anatomie & Histologe, IV/2, Springer Verlag, Berlin, 768-1116, 1928.

• 9) Morson, B. C.:Gastric polyps composed of intestinal epithelium Br. J. Cancer 9, 550-557, 1955.
  pubmed

• 10) Ming, S-C, and Goldman, H.:Gastric polyps. A histogenetic classification and its relation to carcinoma. Cancer 18, 721-726, 1965,
  pubmed

• 11) Tomasulo, J.:Gastric polyps. Histologic types and their relationship to gastric carcinoma. Cancer 27, 1346-1355, 1971.
  pubmed

• 12) 松本道也, 島峰徹郎, 中島幹雄, 吉場 朗, 湖山聖道, 中島哲二, 五十子彌大, 平塚 任, 竹本忠良, 水野美淳, 松尾 裕, 中西孝雄, 福地創太郎, 安孫子淳:消化器の前癌病変. 老年病(臨増号) 6, 158-161, 1962.

• 13) 中村卓次:胃ポリープ.日本臨牀 22, 1979-1987, 1964.
  Medical*Online

• 14) 長与健夫:胃粘膜上皮の異型増殖について. 癌の臨床 12, 400-405, 1966.

• 15) 福地創太郎, 望月孝規:胃隆起性病変の診断におけるFGS生検の意義. Gastroent. Endoscopy 9, 105-107, 1967.

• 16) 佐野量三:胃腺腫性ポリープの分類とその癌化について. 胃と腸 3, 725-728, 1968.

• 17) 谷口春生:良性-悪性境界領域病変を中心に, 日本合同癌会議シンポジウム記録. 81-87, 1970.

• 18) Watanabe, H.:Argentaffin cells in adenoma of stomach. Cancer 30, 1267-1274, 1972.
  pubmed

• 19) 渡辺英伸:非癌胃粘膜, 胃腺腫および胃癌内の嗜銀細胞. 癌の臨床 20, 519-535, 1974.

• 20) 喜納 勇, 加藤 洋, 保坂茂文:胃扁平腺腫(flat adenoma) の病理組織学的ならびに電顕的研究-特にその本態についての考察.日病会誌 65, 211-212, 1976.

• 21) WHO(Oota,K.) :Histological typing of gastric and esophageal tumors. WHO, Geneva, 1977.

• 22) Morson B. C., Sobin, L. H., Grundmann, E., Johansen, A., Nagayo, T. and Serck-Hansen, A.:Precancerous conditions and epithelial dysplasia in the stomach. J. Clin. Path.33, 711-721, 1980.

• 23) Nagayo, T.:Dysplasia of the stomach. Gann.72, 813-823, 1981.
  pubmed

• 24) 福地創太郎, 望月孝規:胃隆起性病変の背景としての胃粘膜病変と胃液分泌機能. 胃と腸 10, 179-183, 1975.

• 25) 中村卓二:胃ポリープの病型-腺腫を中心に.最新医学 36, 5-20, 1981.

• 26) Correa, P., Cuello, C. and Duque, E.:Carcinoma and intestinal metaplasia of the stomach in Columbian migrants, J. Nat. Cancer Inst.44, 297-306, 1970.

• 27) Imai, T., Kubo, T. and Watanabe, H.:Chronic gastritis with reference to high incidence of gastric carcinoma J. Nat. Cancer Inst.47, 179-195, 1971.
  pubmed

• 28) 中村恭一, 菅野晴夫, 高木国夫, 熊倉賢二:胃粘膜の経時的変化とその立場からみた胃癌の組織発生. 外科治療 23, 435-448, 1970.

• 29) Nakano, G. and Nakamura, T.:Histopathological study of intestinal metaplasia of postmortem stomachs in the aged Japanese. Cancer Detection and Prevention.4, 361-368, 1981.
  pubmed

• 30) Nakamura, K., Sugano, H. and Takagi, K.:Carcinoma of the stomach in incipient phase. Its histogenesis and histological appearances. GANN 59, 251-258, 1968.
  pubmed

• 31) Jarvi, O. and Lauren, P.:On the role of heterotopias of the intertinal epithelium in the pathogenesis of gastric cancer. Acta Path. Microbiol. Scand(A) 29, 26-44, 1951.

• 32) Morson, B. C.:Carcinoma arising from area of intestinal metaplasia of the gastric mucosa. Br. J. Cancer 9, 377-385, 1955.

• 33) 飯田 太, 丸山雄造:粘液組織細胞化学的立場からみた腸上皮化生の成立について. 日消会誌 75, 1303-1311, 1978.

• 34) 安部宗顕, 大内伸夫, 赤松昌亮, 松本高明:腸上皮化生の酵素組織化学. 胃と腸 6, 875-880, 1971.

• 35) 小堀鴎一郎:胃癌の酵素組織化学的検討.-特に腸上皮との関連について.胃と腸 6, 927-934, 1971.

• 36) Kawachi, T., Kogure, K., Tanaka, N., Tokunaga, A., Sugimura, T., Koyama, Y., Kanasugi, K., Hirota, T. and Sano, R.:Studies of intestinal metaplasia in the gastric mucosa by detection of disaccharases with "Tes-Tape."J. Nat. Cancer Inst.53, 19-30, 1974.

• 37) 松倉則夫, 河内 卓:胃癌発生と腸上皮化生. 最新医学 34, 453-456, 1979.
  Medical*Online

• 38) Matsukura, N., Suzuki, K., Kawachi, K., Aoyagi, M., Sugimura, T., Kitaoka, H., Numaijri, H., Shirota, A., Ikabashi, M. and Hirota, T.:Distribution of marker enzymes and mucinin intestinal metaplasia in human stomachs and relation of complete and incomplete types of intestinal metaplasia to minute gastric carcinoma. J. Nat. Cancer Inst.65, 231-240, 1980.

• 39) 吉田 均, 広田映五, 板橋正幸, 三坂亮一, 小沼千秋, 海上雅光, 小黒八七郎, 吉森正喜, 北岡久三, 平田克治, 河内 卓, 松倉則夫:小胃癌の背景粘膜-腸上皮化生粘膜, とくに不完全型との関係. Progress of Digestive Endoscopy 17, 120-124, 1980.

• 40) 広田映五, 吉田 均, 小沼千秋, 板橋正幸, 海上雅光, 岡田俊夫, 松倉則夫, 小黒八七郎, 北岡久三;不完全型腸上皮化生と諸胃疾患-特に腫瘍性病変の前駆病変としての意義 Progress of Digestive Endoscopy 18, 52-57, 1980.

• 41) 中原國広, 友田博次, 林逸郎, 古澤元之助, 安部宗顕, 大町彰二郎, 良永拓国, 瀬尾洋介, 嶺博之:新しい酵素化学的アプローチによる胃粘膜腸上皮化生の特徴と胃癌との相互関係.胃と腸 13, 103-112, 1978.

• 42) Cruveilhier, I.:Maladies de I'estomac. Tome 1, 1829(文献45) による).

• 43) 山極勝三郎:胃癌発生論(原版:半田屋医籍商店, 東京, 1905).形成社, 東京, 1981.

• 44) Hauser, G.:Die peptische Schadigungen des Magens, des Duodenums und der Speiserohre und das peptische postoperative Jejunalgeschw?r. In:Heuke, F u Lubarsch, U:Handbuch d. spez. path. Anatomie u Histologie, IV/1, Springer Verlag, Berlin, 339-811, 1926.

• 45) Newcomb, W. D.:The relationship between peptic ulceration and gastric carcinoma. Brit. J. Surg.20, 279-308, 1932.

• 46) Stromeyer, F.:Die Pathogenese des Ulcus ventriculi, Zugleichen Beitrag zur Frage nach den Beziehungen Zwschen Ulcus and Karzinom. Ziegler's Beitr, path Anat u. allg. path.65, 1-67, 1912.

• 47) Konjetzny, G. E. Uber die Beziehung der chronischen Gastitis mit ihren Folgeerscheinungen und des chronischen Magenulcus zur Entwicklung des Magenkrebses. Brun's Beitr. K1 Chirurgie. 85, 455-519, 1913.

• 48) 今井 環:胃潰瘍癌の解析, 医学のあゆみ 62, 471, 1967.

• 49) McCarty, W. C.:Chronic ulcer and carcinoma of the stomach. Amer. J. Med. Science.173, 466-472, 1927.

• 50) 村上忠重, 漆原春樹, 中村暁史, 宮下美正:胃潰瘍と胃癌(広義の潰瘍癌について).治療 42, 261-266, 1960.

• 51) 太田邦夫:胃癌の発生.日病会誌 53, 3-16, 1964.

• 52) Krause, U.:Long-term results of medical and surgical treatment of peptic ulcer. Acta. Chir. Scand. Suppl.310, 1963.

• 53) Ihre, B. J. E., Barr, H. and Havermark, G.:Ulcer-cancer of the stomach. A follow-up study of 473 cases of gastic ulcer. Gastro Enterologia(Base1).102, 78-91, 1964.

• 54) Hirohata, T.:Mortality from gastric cancer and other causes after medical or surgical treatment for gastric ulcer. J. Nat. Cancer Inst.41, 895-908, 1968.
  pubmed

• 55) 勝木司馬之助, 岡部治弥, 小田切茂雄, 尾石泰行, 広門一孝, 藤井道英, 増田信生, 八尾恒良, 古賀安彦, 堀之内幸士, 吉田隆亮, 安河内律, 桑原廉靖:胃癌の経過に関する研究(第3報), 悪性腫瘍の表 面変化について.Gastroenterol. Endoscopy.7, 94-96, 1965.

• 56) 堀之内幸士, 古賀安彦, 岡部治弥:胃癌病巣内潰瘍の消長. 胃と腸3, 1673-1682, 1968.

• 57) 村上忠重:胃潰瘍癌に関する新しい考え方(悪性サイクル). 順天堂医学会雑誌 13, 157-165, 1967.

• 58) 藤井 彰, 淵上在弥, 上野正次, 松崎俊道:前癌病変-胃集検の立場から. 最新医学 31, 1182-1188, 1976.

• 59) 五ノ井哲朗, 植木洋司:胃潰瘍の時代的変貌. 胃と腸 15, 27-33, 1980.

• 60) 田村浩一:胃癌検診.癌の臨床 28, 637-687, 1982.

• 61) 原 義雄, 小越和栄, 飛田祐吉, 丹羽正之, 斉藤征史, 栗田雄三, 筒井一哉, 佐藤正之, 千原 明, 木滑孝三, 堀川紘三, 村川英三:胃潰瘍の癌化について-臨床的follow upを中心に. 胃と腸11, 565-572, 1976.

P.93 掲載の参考文献

• 1) 井口 潔, 犬塚貞光, 古沢元之助, 副島一彦, 池田俊彦:再発症例からみた表在胃癌の発育について. 外科治療 13, 1-13, 1965.

• 2) 井口 潔, 古沢元之助, 副島一彦, 三戸康郎, 池田俊彦, 原口幸昭, 阿部和哲, 川崎重義:早期胃癌の反省と今後の問題点-発育パターンからみた臨床病理学的考察-. 日本医事新報2211, 3-9, 1966.

• 3) Kodama, Y., Inokuchi, K., Soejima, K., Matsusaka, T. and Okamura, T.:Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types. Cancer 51, 320-326, 1983.
  pubmed

• 4) Inokuchi, K., Kodama, Y., Sasaki, O., Kamegawa, T. and Okamura, T.:Differentiation of growth patterns of early gastric carcinoma determined by cytophotometric DNA analysis. Cancer 51, 1138-1141, 1983.
  pubmed

• 5) Noda, S., Soejima, K. and Inokuchi, K.:Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn. J. Surg.10, 277-283, 1980.
  pubmed

• 6) 井口 潔, 児玉好史, 佐々木 攻:Pen型からみた早期胃癌考.目本医事新報 2957, 12-16, 1980.

P.106 掲載の参考文献

• 1) Muto, T., Bussey, H. J. and Morson, B. C.:The evolution of cancer of the colon and rectum. Cancer.36, 2251-2270, 1975.
  pubmed

• 2) 武藤徹一郎, 石川浩一, 喜納勇・他:日本と英国の大腸腺腫の差に関する組織学的研究. 癌の臨床 23, 465-468, 1977.

• 3) 上谷潤二郎, 武藤徹一郎, 小西文雄・他:大腸ポリープの内視鏡的摘除臨床成人病11, 1921-1926, 1981.

• 4) Muto, T., Kamiya, J., Sawada, T. et al.:Colonoscopic polypectomy in diagnosis and treatment of early carcinoma of the large intestine. Dis. Colon Rectum.23, 68-75, 1980.
  pubmed

• 5) Muto, T., Kamiya, J., Sawada, T. et al.:Morphogenesis of human colon cancer. Dis. Colon Rectum. 26, 257-262, 1983.
  pubmed

• 6) 武藤徹一郎, 上谷潤二郎, 小西文雄・他:大腸ポリープの病理と腺腫の癌化.最新医学36, 80-87, 1981.

• 7) Welin, S., Youker, J., Spratt, J. S. Jr. et al.:The rates and patterns of growth of 375 tumors of the large intestin and rectum observed serially by double contrast enema study. Am. J. Roentgenol 90, 673-687, 1963.

• 8) 牛尾泰輔, 阿部荘一, 光島徹・他:大腸癌のX線像による遡及的検討.胃と腸14, 537-547, 1979.

• 9) 武藤徹一郎, 上谷潤二郎, 沢田俊夫・他:臨床的に大腸ポリープ(腺腫) から癌への変化が観察された3症例の報告.日消誌 76, 1851-1856, 1979.

• 10) 武藤徹一郎, 上谷潤二郎, 沢田俊夫・他:大腸の小さな平坦隆起性病変(small "flat elevation") の臨床病理学的検討.-胃と腸印刷中,

• 11) Crawford, B. E. and Stromeyer, F. W.:Small nonpolypoid carcinomas of the large intestine. Cancer 51, 1760-1763, 1983.
  pubmed

• 12) Spratt, J. S. Jr. and Ackerman, L. V.:Small primary adenocarcinomas of the colon and rectum. JAMA.179, 337-346, 1962.
  pubmed

• 13) Oohara, T., Ogino, A., Saji, K. et al.:Studies on the difference of background mucosa among single advanced carcinoma and benign disease of the large intestine and familial polyposis coli. Cancer 45, 1637-1645, 1980.
  pubmed

• 14) Shamsuddin, A. M.:Microscopic intraepithelial neoplasia in large bowel mucosa. Human Pathol.13, 510-512, 1982.
  pubmed

• 15) 高橋康平, 武藤徹一郎,沢田俊夫・他:多発癌を合併した多発性大腸腺腫の2症例. 大腸肛門誌36, 28-32, 1983.

• 16) 辻仲康伸, 土屋周二, 大木繁男・他:IIc 型直腸早期癌-de novo発生の1例.胃と腸 18, 211-217, 1983.

• 17) Filipe, M.I.:The value of a study of the mucosubstances in rectal biopsies from patients with carcinoma of the rectum and lower sigmoid in the diagnosis of premalignant mucosa. J. Clin. Path. 25, 123-128, 1972.
  pubmed

• 18) Shamsuddin, A. K. M., Weiss, L., Phelps, P. C. et al.:Colon epithelium. IV. Human colon carcinogenesis. changes in human colon mucosa adjacent to and remote from carcinomas of the colon. JNCI 66, 413-419, 1981.

• 19) 沢田俊夫, 武藤徹一郎, 阿川千一郎・他:大腸腺腫ならびに担癌大腸粘膜の杯細胞粘液組成について. 胃と腸 18, 1235-1245, 1983.

• 20) Culling, C. F. A., Reid, P. E., Worth, A. J. et al.:A new histochemical technique of use in the interpretation and diagnosis of adenocarcinoma and villous lesions in the large intestin. J. Chin. Path, 30, 1056-1062, 1977.

• 21) 武藤徹一郎,上谷潤二郎, 小西文雄・他:Periodic Acid-Thionin Schiff/Potassium Hydroxide/Periodic Acid-Schiff(PAT/KOH/PAS) 染色によるヒト大腸粘液の染色性. 胃と腸 17, 343-348, 1982.

• 22) 武藤徹一郎:大腸癌発生の臨床病理.代謝 Vol. 19, 「癌 '82」p.265-278, 中山書店, 東京, 1982.

• 23) 山田直行,福地創太郎,小川高伴・他:腺腫内癌を合併した大腸多発性化生性ポリープの1例.胃と腸 18, 523-530, 1983.

• 24) Riddell, R. H.:Precarcinomatous phase of ulcerative colitis. in Current Topics in Pathology, ed. by B. C. Morson, Springer-Verlag. Bulin, p.177-219, 1976.

• 25) LaMont, J. T, and O'Gorman, T. A.:Experimental colon cancer. Gastroenterology 75, 1157-1169, 1978.

• 26) 上谷潤二郎, 武藤徹一郎;1, 2-Dimethyl-hydrazineによるウィスター系ラット実験大腸癌の検討-特に好発部位の癌の組織発生について-日消誌 75, 1934-1946, 1978.

• 27) Shamsuddin, A. K. M. and Trump, B. F.:Colon epiithelium, II In vivo studies of colon carcinogenesis. Light microscopic, histochemical, and ultrastructural studies of histogenesis of azoxymethane-induced colon carcinomas in Fischer 344 rats. JNCI.66, 389-401, 1981.

• 28) 上谷潤二郎, 斉藤幸夫, 武藤徹一郎・他:DMH誘発ラット実験大腸癌の検討.目消誌 80, 1731-1734, 1983.

P.116 掲載の参考文献

• 1) Okuda, K., Kubo, Y., Okazaki, N. et al.:Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. A study of 57 autopsy cases. Cancer.39, 232-246, 1977.
  pubmed

• 2) Brechot, C., Pourcel, C., Hadchouel, M. et al.:State of hepatitis B virus liver diseases. Hepatology.2, 27S-34S, 1982.

• 3) Shafritz, D.:Hepatitis B virus DNA molecules in the liver of HBsAg carriers:mechanistic considerations in the hepathogenesis of hepatocellular carcinoma. Hepatology.2, 35S-41S, 1982.

• 4) Okuda, K. and Beasley, R. P.:Epidemiology of hepatocellular carcinoma. In:Hepatocellular Carcinoma, Okuda K, Mackay I, eds. UICC Workshop 1982. UICC Geneva, 1983.

• 5) Linsell, D. A. and Higginson, J.:The geographic pathology of liver cell cancer. In:Liver Cell Cancer. Cameron, Linsell, Warwick, eds. Elsevier, Amsterdam, 1-16, 1976.

• 6) Nayak, N. C., Dhar, A., Sachadeva, R. et al.:Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigen in the liver. Int. J. Cancer.20, 643-654, 1977.

• 7) Munoz, N. and Linsell, A.:Epidemiology of primary liver cancer. In:Epidemiology of Cancer of the Digestive Tract. Correa P, Haenszel W, eds, Martinus Nijhoff, Hague, 161-195, 1982.

• 8) Miyaji, T.:Association of hepatocellular carcinoma with cirrhosis among autopsy cases in Japan during 14 years from 1958 to 1971. Gann.18, 129-149, 1976.

• 9) Segi, M. and Kurihara, M.:Trends in cancer mortality for selected sites in 24 countries, 1950-1959.Tohoku Univ. School of Public Health, Sendai, 24-25, 43-44, 1963.

• 10) Oon, C. J., Okuda, K. and Pang, R.:Primary hepatocellular carcinoma in the Asian Pacific region. Ann. Acad. Med.9, 190-192, 1980.

• 11) Peters, R. L.:Pathology of hepatocellular carcinoma. In:Hepatocellular Carcinoma. Okuda K, Peters RL, eds. Wiley, New York, 107-168, 1976.

• 12) Saracci, R. and Repetto, F.:Time trends of primary liver cancer:indication of increased incidence in selected cancer registry populations. J. Natl. Cancer Inst.65, 241-247, 1980.

• 13) Beasley, R. P., Hwang, L Y., Lin, C. C. et al.:Hepatocellular carcinoma and hepatitis B virus. Lancet.2, 1129-1133, 1981.
  pubmed

• 14) Sakuma, K., Takahara, T., Okuda, K. et al.:Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests:a prospective study. Gastroenterology.83, 114-117, 1982.
  pubmed

• 15) Omata, M., Ashcavai, M., Liew, C. T. et al.:Hepatocellular carcinoma in the U. S., etiologic considerations. Localization of hepatitis B antigen. Gastroenterology.76, 279-287, 1979.

• 16) Okuda, K., Nakashima, T., Sakamoto, K. et al.:Hepatocellular carcinoma in noncirrhotic andhighly cirrhotic livers;a comparative study of histopathology and frequency of hepatitis B markers. Cancer.49, 450-455, 1982.

• 17) Okuda, K., Nakashima, T. and Obata, H.:Hepatitis B virus and primary liver cell carcinoma. In:Virus and the Liver. Bianchi L, et al, eds. Lancaster, MTP Press, 309-216, 1980.

• 18) VanKaick, G., Lieberman, D., Lorenz, D. et al.:Recent results of the German Thorotrast study-epidemiological results and dose effect relationships in Thorotrast patients. Health Physics 44, Suppl.1, 299-306, 1983.

• 19) Shinagawa, T., Ohto, M., Kimura, K. et al.:Diagnosis and clinical feature of small hepatocellular carcinoma with ernphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology.86, 495-502, 1984.
  pubmed

• 20) 日本肝癌研究会:原発性肝癌に関する追跡調査-第5報.肝臓 23, 675-681, 1982.

• 21) Okuda, K., Peters, R. L and Simson, I. Gross anatomical features of hepatocellular carcinomafrom three disparate geographic areas-proposal of new classification. Cancer(in press).

• 22) Steiner, P. E.:Cancer of the liver and cirrhosis in Trans-Saharan Africa and the United States of America. Cancer.13, 1085-1166, 1960.

• 23) Berman, C.:Primary Carcinoma of the Liver. A Study in Incidence, Clinical Manifestations, Pathology and Aetiology. Lewis, London, 1951.

• 24) Lee, F.I.:Cirrhosis and hepatoma in alcoholics. Gut.7, 77-85, 1966.
  pubmed

P.125 掲載の参考文献

• 1) Klein, J.:Biology of the Mouse Histocompatibility-2 Complex. Springer-Verlag, Berlin, Hedelberg, New York, 1975.

• 2) Zinkernagel, R. M.:Speculation on the role of major transplantation antigen in cell-mediated immunity against intracellular parasites:Current Topics in Microbiology and Immunology.82, 113, 1978.
  pubmed

• 3) Sanders, G. F.(ed) :Cell Differentiation and Neoplasia. Raven Press, New York, 1978.

• 4) McKenzie, I. F. C. and Pottor, T.:Murine lymphocyte surface antigens:Advances in Immunology.27, 179, 1979.

• 5) Hynes, R. U. and Fox, C. F.:Tumor Cell Surfaces and Malignancy. Alan R, Liss, Inc. New York, 1980.

• 6) Dorf, M. E.:The Role of the Major Histocompatibility Complex in Immunobiology. Garland STPM Press, New York & London, 1981.

• 7) Waters, H.:The Handbook of Cancer Immunology. Vol.8, Tumor antigens:Structure and Function, Garland STPM Press, New York & London, 1981.

• 8) 漆崎一朗:腫瘍マーカーとしての酵素.医学のあゆみ 121, 1105, 1982.

• 9) Klein, J.:Immunology, The science of self-nonself discrimination. A Wiley-lnterscience Publication, New York, Chichester, Brisbane, Toronto, Singapore, 1982.

• 10) Schwartz, L. M.:Compendium of Immunology. Vol.I(1980), Vol. II(1982), Vol.III(1983), van Nostrand Reinhold Company, New York.

P.136 掲載の参考文献

• 1) Williams, E. D. and Sandler, M.:The classification of carcinoid tumors. Lancet.1, 238-239, 1963.
  pubmed

• 2) Soga, J. and Tazawa, K.:Pathologic analysis of carcinoids. Cancer.28, 990-998, 1971.
  pubmed

• 3) Welbourn, R. B.:Apudomas of the gut. Amer. J. Surg.13-22, 1976.

• 4) Larsson, L-I.:Pathology of gastrointestinal endocrine cells. Scand. J. Gastroent. Suppl.14, 1-8, 1979.

• 5) 曾我 淳:いわゆる Apudomaと消化管Carcinoid(Urgut Endocrinoma). 臨床科学 13, 1362-1369, 1977.

• 6) Fontaine, J. and Le Douarin, N. M.:Anaiysis of endoderm formation in the avian blastoderm by the use of quailchick chimeras. The problem of the neuroectoderm origin of the APUD series. J. Embryol. Exp. Morphol.41, 209-222, 1977.

• 7) Sidhu, G. S.:The endodermal origin of digestive and respiratory tract APUD cells. Am J. Pathol.96, 5-20, 1979.
  pubmed

• 8) Cox, Jr. W. F. and Pierce, G. B.:The endodermal origin of the endocrine cells of an adenocarcinoma of the colon of the rat. Cancer.50, 1530-1538, 1982.

• 9) Rode, J., Dhillon, A. P. and Papadaki, L.:Serotonin-immunoreactive cells in the lamina propria plexus of the appendix. Hum Pathol.14, 464-469, 1983.
  pubmed

• 10) Aubock, L. and Hofler, H.:Extraepithelial intraneural endocrine cells as starting points for gastrointestinal carcinoids. Virchows Archiv.(Path. Anat.) 401, 17-33, 1983.

• 11) 笹野伸昭, 木村伯子, 小島元子:カルチノイドの病理と生化学. 日本臨床 38, 2788-2797, 1980.
  Medical*Online

• 12) 笹野伸昭, 増田高行:消化管カルチノイド病理組織外科 44, 1377-1382, 1982.

• 13) 第17回大腸癌研究会:直腸カルチノイドアンケート調査報告書. p.1-11, 仙台, 1982.

• 14) Sjolund, K., Sanden, G, Hakanson, R. et al.:Endocrine cells in human intestine:An immunocytochemical study. Gastroenterol.85, 1120-1130, 1983.

• 15) 佐藤寿昭, 檜沢一夫, 下田忠和:カルチノイドおよび類縁腫瘍におけるペプタイドホルモンの局在. 病理と臨床 1, 1315-1328, 1983.

• 16) Godwin, J. D. II.:Carcinoid tumors. An analysis of 2837 cases. Cancer.36, 560-569, 1975.

• 17) Soga, J.:Carcinoids of the rectum, tumors of the carcinoid family-Urgut endocrinomas. Acta Medica et Biologica.29, 157-201, 1982.

• 18) Rumpf, P., Ulrich, B., Krian, A. et al.:Rektumkarzinoide. Dtsch. Med. Wschr.101, 1531-1533, 1976.

• 19) Alumets, J., Alm, P., Falkmer, S. et al.:Immunohistochemical evidence of peptide hormones in endocrine tumors of the rectum. Cancer.48, 2409-2415, 1981.
  pubmed

• 20) Weichert, R. F. III., Roth, L. M. and Harkin, J. C.:Carcinoid-islet cell tumor of the duodenum and associated multiple carcinoid tumors of the ileum. Cancer.27, 910-918, 1971.

• 21) Kaneko, H., Yanaihara, N., Ito, S. et al.:Somatostatinoma of the duodenum. Cancer.44, 2273-2270, 1979.
  pubmed

• 22) 笹野伸昭:消化器のFunctioning Tumorの病理 日本消化器外科学会雑誌 15, 1681-1689, 1982.

• 23) 笹野伸昭:腺癌における好銀細胞の位置づけ. 医学のあゆみ 110, 671-672, 1979.

• 24) 長田孝義:胃癌組織内の抗ガストリン抗体陽性細胞. 福岡医学雑誌 68, 327-348, 1977.

• 25) Tahara, E., Ito, H., Nakagami, K. et al.:Scirrhous argyrophil cell carcinoma of the stomach with multiple production of polypeptide hormones, amine, CEA, lysozyme, and HCG. Cancer. 49, 1904-1915, 1982.
  pubmed

• 26) 仲村春和:神経堤細胞の発生, 移動と分化. 脳神経 36, 27-35, 1984.

• 27) Soga, J.:Histogenesis of carcinoids in relation to ordinary carcinomas. Acta Medica et Biologica. 30, 17-33, 1982.

• 28) Ljungberg, O., Jarnerot, G., Rolny, P. et al.:Human pancreatic polypeptide(HPP) immunoreactivity in an infiltrating endocrine tumor of the papilla of Vater with unusual morphology, Virchows Arch(Pathol Anat) 392, 119-126, 1981.

P.148 掲載の参考文献

• 1) Lajtha, L. G.:Stem cell concepts. Differentiation.14, 23-34, 1979.
  pubmed

• 2) 藤田哲也:細胞動態からみた胃癌の発生と進展. 日病会誌 70, 23-25, 1981.

• 3) 森 和博:多能幹細胞の統御機構.代謝 15, 107-117, 1978.

• 4) Vogel, H., Niewisch, H. and Matioli, G.:The self renewal probability of hemopoietic stem cells. J. Cell. Physiol.72, 221-228, 1968.
  pubmed

• 5) 杉山 勉:ヒドラの幹細胞. 代謝 20, 1621-1628, 1983.

• 6) Chervenick, P. A. and Boggs, D. R.:Patterns of proliferation and differentiation of hematopoietic stem cells after compartment depletion. Blood.37, 568-580, 1971.
  pubmed

• 7) Carins, J.:Mutation selection and the natural history of cancer. Nature.255, 197-200, 1975.

• 8) 森 和博:造血幹細胞分化の統御機構. 細胞工学 2, 1375-1386, 1983.

• 9) Ashihara, T., Kitamura, T., Takeoka, O., Fujita, S., Kodama, M., Shinoda, M. and Hashimoto, I.:Autoradiographic studies on cell proliferation and differentiation in the human epidermis in vivo. Arch. histol. Japon.28, 399-410, 1967.

• 10) 江口吾朗:幹細胞とは何か. 代謝 20, 1607-1615, 1983.

• 11) Potten, C. S., Schofield, R. and Lajtha, L G.:A comparison of cell replacement in bone marrow, testis and three regions of surface epithelium. Biochim. Biophys. Acta.560, 281-299, 1979.
  pubmed

• 12) Edwards, J. L and Koch, A.:Parenchymal and littoral cell proliferation during liver regeneration. Laboratory Invest.13, 32-43, 1964.

• 13) 北村幸彦, 園田 隆:血液幹細胞-生物学的側面-. 代謝 20, 1637-1642, 1983.

• 14) 小野江為則:アゾ色素肝がん. 肝がん(小野江為則編) 講談社, pp.52-76, 1974.

• 15) Fialkow, P. J.:Clonal origion of human tumors. Biochim. Biophys. Acta.458, 283-321, 1976.

• 16) Kakizoe, T., Tanooka, H., Tanaka, K. and Sugimura, T.:Single-cell origin of bladder cancer induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice with cellular mosaicism. Gann. 74, 462-465, 1983.

• 17) Leblond, C. P., and Cheng, H.:Identification of stem cells in the small intestine of the mouse.in Stem cells of Renewing Cell Population(ed. A. B. Cairnie & P, K. Lala) Academic Press, New York, pp.7-31, 1976.

• 18) Matsuyama, M., Nakamura, T., Suzuki, H., Ito, M., Yamada, S. and Nagayo, T.:Early lesions in carcinogenesis by N-ethyl-N'-nitrosoguanidine in mouse duodenum. in Pathophysiology of Carcinogenesis in Digestive Organs(ed. E. Farber et al.) Univ. of Tokyo Press, Tokyo, pp. 269-382, 1977.

• 19) 西塚泰章:幹細胞-癌との関連において-. 代謝 20, 1653-1662, 1983.

• 20) 別所正美, 陣内逸郎, 平嶋邦猛:白血病と造血幹細胞. 細胞工学 2, 1431-1441, 1983.

• 21) Hall, A. K.:Stem cell is a stem cell is a stem cell, Cell.33, 11-12, 1983.
  pubmed

• 22) 北村幸彦:血球分化の遺伝的統御.代謝 15, 119-125, 1978.

• 23) Ozato, K., and Wakamatsu, Y.:Multi-step genetic regulation of oncogene expression in fish hereditary melanoma. Differentiation.24, 181-190, 1983.
  pubmed

• 24) Cooper, G. M.:Cellular transforming genes. Science.218, 801-806, 1982.

• 25) Klein, G.:The role of gene dosage and genetic transpostions in carcinogenesis. Nature.294, 313-318, 1981.

• 26) Stevens, L C.:The biology of teratomas. in Advances in Morphogenesis(ed. M. Abercrombie &J.Brachet) Academic Press. New York, vol.6, pp.1-31, 1967.

• 27) Mintz, B. and Illmensee, K.:Normal gentically mosaic mice procued from malignant teratocarcinoma cells. Proc. Nat. Acad. Sci. USA.72, 3585-3589, 1975.

• 28) Calos, M. P., Johnsrud, L. and Miller, J. H.:DNA sequence at the integration sites of the insertion element ISI. Cell.13, 411-418, 1978.

• 29) Mori, K. J., Amano, M. and Osogoe, B.:Radioautographic study on the incorporation of tritiated thymidine by mouse liver cells during restitution after starvation. Acta histochem. cytochem.2, 124-130, 1969.

• 30) Mori, K. J.:Nucleic acid synthesis in the mouse liver during restitution after starvation. Acta Med. Okayama.22, 1-9, 1968.
  pubmed

• 32) Pelc, S. R.:Labelling of DNA and cell division in so called non-dividing tissues. J. Ceil Biol. 22, 21-28, 1964.

• 33) McCulloch, E. A., Siminovitch, L, Till, J. E., Russell, E. S. and Bernstein, S. E.:The cellular basis of the gentically determined hemopoietic defect in anemic mice of genotype Sl/Sld. Blood. 26, 399-410, 1965.

• 34) Greenberger, J. S., Davidson, P. B. and Gans, P. J.:Murine sarcoma viruses block corticosteroid-induced differentiation of bone marrow preadipocytes associated with long-term in vitro hemopoiesis. Virology.95, 317-333, 1979.

• 35) 森 和博:造血における細胞間相互作用. 代謝 21, 325-335, 1984.

• 36) Smadja-Joffe, F., Klein, B., Kerdiles, C., Feinendegen, L. and Jasmin, C.:Study of cell death in Friend leukaemia. Cell Tissue Kinet.9, 131-145, 1976.
  pubmed

• 37) Mager, D., Mak, T. W. and Bernstein, A.:Friend leukaemia virus-transformed cells, unlike normal stem cells, form spleen colonies in Sl/Sld mice. Nature.288, 592-594, 1980.

• 38) 日合 弘:白血病の増殖過程.代謝 20, 805-812, 1983.

• 39) 藤田哲也:胃癌発生における"前癌性病変"の意味-細胞動態の立場より-.癌と化学療法 10, 459-470, 1983.

II 消化器がんの診断・治療の進歩

P.157 掲載の参考文献

• 1) 食道疾患研究会編:臨床・病理食道癌取扱い規約.金原出版,東京,1976.

• 2) 鍋谷欣市・他:早期食道癌-定義と全国集計を中心に-. 日気食会報 32(6), 393-399, 1981.

• 3) 村田洋子・他:食道癌における腹腔内転移リンパ節の超音波診断の検討. 日消外会誌 14(7), 1005-1015, 1981.

• 4) Picus, D. et at.:Computed tomography in the staging of esophageal carcinoma. Radiol 146, 433-438, 1983.

• 5) 遠藤光夫・他:食道癌早期診断の進歩.消化器外科セミナー7, 中山恒明編, へるす出版, 東京, 7-20, 1982.

• 6) 遠藤光夫:早期食道癌の診断.順天堂医学 26(4), 419-423, 1980.

• 7) 山田明義・他:食道X線が内視鏡に期待するもの.胃と腸 14(3), 311-317, 1979.

• 8) 井手博子・他:食道m, sm癌の臨床病理-診断ならびに治療上の問題点について-. 日気食会報 32(6), 413-421, 1981.

• 9) 植松貞夫・他:早期食道癌の検討.日気食会報 32(16), 400-405, 1981.

• 10) 植松貞夫・他:sm食道癌のX線学的検討. 臨放 26(6), 629-633, 1981.

• 11) 山田明義・他:食道癌スクリーニングにおけるX線の役割.胃と腸 19(2), 129-139, 1984.

• 12) 片山 泰・他:早期食道癌のX線学的検討. 日本医放会誌 41(1), 194-201, 1980.

• 13) 山本勇・他:m癌のX線診断を中心に.臨放 27(10), 1015-1021, 1982.

• 14) 幕内博康・他:食道癌スクリーニングにおけるpanendoscopyの位置づけ.胃と腸 19(2), 141-153, 1984.

P.165 掲載の参考文献

• 1) Cotton, R. G. H. and Milstein, C.:Fusion of two immunoglobulin-producing myeloma cells. Nature.244, 42-43, 1973.

• 2) Kohler, G. and Milstein, C.:Continuous cultures of fused cells secreting antibody of predefined specificity. Nature.256, 495-497, 1975.
  pubmed

• 3) Raschke, W. C.:Plasmacytomas, lymphomas and hybridomas:their contribution to immunology and molecular biology. Biochim. Biophysica Acta.605, 113-145, 1980.

• 4) Raschke, W. C.:Monoclonal antibodies to human tumor antigens p.1-32 in Human Cancer Markers, ed. by Sell, S. and Wahren, B., Humana Press. Clipton, New Jersey.1982.

• 5) Uotila, M., Engvall, E. and Ruoslahti, E.:Monoclonal antibodies to human alphafetoprotein. Molecular Immunology.17, 791-794, 1980.

• 6) Koprowski, H., Steplewski. Z., Mitchell, K., Herlyn, M., Herlyn, D. and Fuhrer, P.:Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genetics.5, 957-971, 1979.
  pubmed

• 7) Herlyn, M., Steplewski, Z., Herlyn, D. and Koprowski, H.:Colorectal carcinoma-specific antigen:Detection by means of monoclonal antibodies, Proc. Natl. Acad. Sci.76, 1438-1442, 1979.
  pubmed

• 8) Koprowski, H., Herlyn, M., Steplewski, Z. and Sears, H. F:Specific antigen in serum of patients with colon carcinoma. Science.212, 53-55, 1981.
  pubmed

• 9) Magnani, J. L, Brockhaus, M., Smith, D. F., Ginsburg, V., Bleszczyk, M., Mitchell, K. F., Steplewski, Z. and Koprowski, H.:A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science.212, 55-56, 1981.

• 10) Steplewski, Z. and Koprowski, H.:Monoclonal antibody defined antigens of gastro-intestinal tumors. Federation Proceedings.41, 726, 1982.

• 11) Del Villano, B., Sears, H., Barnes, J., Space, S., Brennan, S., Rake, B., Bucher, C., Lin, V., Schoemaker, H. and Zurawski Jr. V.:Monoclonal antibody IRMA for the diagnosis of gastrointestinal cancers. Ciinical Chemistry.28, 1583, 1982.

• 12) Magnani, J., Nilsson, Bo., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H. and Ginsburg, V.:The antigen of a tumor specific monoclonal antibody is a ganglioside containing sialylated lacto-N-fucopentaose II, Federation Proceedings.41, 898, 1982.

• 13) Sears, H. F., Herlyn, M., Del Villano, B., Steplewski, Z. and Koprowski, H.:Monoclonal antibody detection of a circulating tumor-associated antigen II. A longitudinal evaluation of patients with colorectal cancer. J. Clin. Immunol.2, 141-149, 1982.

• 14) Atkinson, B. F, Ernst, C. S., Herlyn, M., Steplewski, Z., Sears, H. F. and Koprowski, H.:Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Research.42, 4820-4823, 1982.
  pubmed

• 15) Del Villano, B., Brennan, S., Brock, P., Bucher, C., Lin, V., McClure, M., Rake, B., Space, S., Westrick, B., Schoemaker, H. and Zurawski, Jr. V. R.:Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA19-9. Clinical Chemistry.29, 549-552, 1983.

• 16) Del Villano, B. C. and Zurawski, Jr, V. R.:Detection of a carbohydrate antigenic determinant (CA19-9) in the serum of cancer patients using a monoclonal antibody radioimmunometric assay. 未印刷.

• 17) Magnani, J. L, Steplewski, Z., Koprowski, H. and Ginsburg, V.:The gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients is a mucin. Cancer Resecarch.43, 5489-5492, 1983.

• 18) Pak, K. Y., Blaszczyk, M., Herlyn, M., Stepiewski, Z. and Koprowski, H.:Identification and isolation of Lewis blood group antigens from human saliva using monoclonal antibodies. 未印刷.

• 19) Blaszczyk, M., Hansson, G. C., Kari-Anders Karlsson, Goran Larson Stromberg, N., Thurins, J., Herlyn, M., Steplewski, Z. and Koprowski, H.:Monoclonal antibodies against human colon carcinoma cell lines detect specifically Lewis blood group antigens.未印刷.

• 20) Herlyn, M., Shen, W. J., Sears, H. F., Civin, C.I, Verrill, H. L, Goldbery, E. M. and Koprowski, H.:Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double-determinant immunoassay with monoclonal antibodies against human blood group determinants. Clin. Exp. Immunol.55, 23-35, 1984.

• 21) Bhattacharya, M. and Barlow, J. J.:Ovarian cystadenocarcinoma-associated antigen(OCAA) p.527-531in Compendium of Assays for Immunodiagnosis of Human Cancer ed. by Herberman Elsevier North Hoiland Inc. Amsterdam.1979.

• 22) Bast, R. C., Lazarus, H. and Knapp, R. C.:A new approach to serotherapy of human ovarian carcinoma. Gynecol. Oncol.10, 370, 1980.

• 23) Bast Jr. R. C., Feeney, M., Lazams, H., Nadler, L M., Colrin, R. B. and Knapp, R. C.:Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest.68, 1331-1337, 1981.

• 24) Bast Jr, R. C., Klng, T. L, John, E. S., Jenison, E., Niloff, J. M. Lazarus, H., Berkonitz, R.S., Leavitt, T., Griffiths, C. T., Parker, L, Zurawski, Jr. V. R. and Knapp, R. C.:A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, New. Engl. J. Med.309, 883-887, 1983.

• 25) Capone, P. M., Papsiders, L D., Croghan, G. A. and Chu, T. M.:Experimental tumoricidal effects of monoclonal antibody against solid breast tumors. Proc, Natl. Acad. Sci.80, 7328-7332, 1983.

• 26) Blaszczyk, M., Pan, K. Y., Herlyn, M., Lindgren, J., Pessano, S., Steplewski, Z. and Koprowski, H.:Characterization of gastrointential tumor-associated carcinoembyonic antigen-relatedantigens difined by monoclonal antibodies. Cancer Research.44, 245-253, 1984.

• 27) Extraction of circulating gastrointeotinal cancer antigen using solid-phase immunoadsorption system of monoclonal antibody-conpled membrane. Journal of Immunological methods.66, 51-58, 1984.

P.173 掲載の参考文献

• 1) Imbriglia, J. E. and Lopusniak, M. S.:Cytologic examination of sediment from the esophagus in a case of intra-epidermal carcinoma of the esophagus. Gastroenterology.13, 457-463, 1949.

• 2) 山形敞一, 石川 誠, 大柴三郎・他:主として細胞診によって診断された早期食道癌の1例. 胃と腸 1, 259-266, 1966.

• 3) 鍋谷欣市, 新井裕二, 川原哲夫・他:早期食道癌-診断と治療の推移-. 外科治療 49, 63-70, 1983.

• 4) The co-ordinating group for the research of esophageal carcinoma, Chinese academy of medical sciences and Honan province.;The early detection of carcinoma of the esophagus. Scientia Sinica.16, 457-463, 1973.

• 5) 李 思元:カプセル法食道擦過細胞診の改良工夫と食道癌診断能の検討.日消外会誌 16, 1606-1614, 1983.

• 6) 舒 儀経:100例早期食管鱗状細胞癌的細胞学研究. 中華腫瘤雑誌 3, 39-41, 1981.

• 7) Torie, S., Kohli, Y., Akasaka, Y. et al.:New trial for endoscopical observation of esophagus by Dye-scattering method. Endoscopy.7, 75-79, 1975.

• 8) 佐野元哉, 奥田 茂, 谷口春生・他:食道癌の内視鏡診断-ルゴール法の応用について-. 外科 Mook. No.24, 25-36, 1982.

P.180 掲載の参考文献

• 1) 白壁彦夫・他:胃疾患X線検査のコツ. 診療 15, 832-841, 1962.

• 2) 白壁彦夫・他:早期胃癌診断の進歩. 内科 14, 227-236, 1964.

• 3) 市川平三郎・他:胃X線診断の実際文光堂, 東京, 1964.

• 4) Shirakabe, H. et at.:Atlas of X-ray diagnosis of early gastric cancer. Igakushoin, Tokyo, 1966.

• 5) 熊倉賢二:図譜による胃X線診断学. 金原出版, 東京, 1968.

• 6) 白壁彦夫・他:X線診断.早期胃癌診断学講座 1, 文光堂, 東京, 1968.

• 7) 白壁彦夫・編:胃二重造影法. 文光堂, 東京, 1970.

• 8) 山田達哉・他:胃隆起性病変. 胃と腸 1, 145-150, 1966.

• 9) 笹川道三:胃潰瘍疲痕のX線学的研究. 日消会誌 63, 428-441, 1966.

• 10) 五井哲郎, 五十嵐 勤:消化管X線読影講座. 胃潰瘍(1), 金原出版, 東京, 1969.

• 11) 市川平三郎・他:胃潰瘍の良-悪性の鑑別診断. 胃と腸 8, 1163, 1973.

• 12) 佐野量造・他:病理からみた胃癌の深達度診断.胃と腸 7, 753, 1972.

• 13) 笹川道三・他:X線診断における陥凹型胃癌の深達度推定, 胃と腸 12, 1209, 1977.

P.188 掲載の参考文献

• 1) 崎田隆夫, 小黒八七郎・他:消化管内視鏡研修の実際中外医学社. 1982.

• 2) 小黒八七郎:胃癌と内視鏡検査(改訂版), 羊土社. 1984.

• 3) 吉田茂昭:胃癌の発育進展に関する内視鏡的アプローチ. 消化器内視鏡の進歩 15, 11-15, 1979.

• 4) 小黒入七郎, 吉田茂昭・他:早期胃癌の変貌-内視鏡診断の立場から-胃と腸 16(1), 47-56, 1981.

• 5) 小黒入七郎:GTFとその役割. 胃と腸 19(1), 35-46, 1984.

P.196 掲載の参考文献

• 1) Wolff, W.I. and Shinya, H.:A New Approach to the Management of Colonic Polyps. Advances in Surgery, Vol.7, Chicago, Year Book Medical Publishers Inc.1973.

• 2) 武藤徹一郎:大腸直腸ポリープの治療方針に関する-考察臨床外科 28, 1243-1250, 1973.

• 3) 武藤徹一郎:大腸ポリープの病理と臨床-. p.221-262, 南江堂, 東京, 1979.

• 4) 上谷潤二郎, 武藤徹一郎, 小西文雄・他:大腸ポリープの内視鏡的摘除臨床成人病 11, 1921-1926, 1981.

• 5) Shinya, H. and Wolff, W.I.:Morphology, Anatomic Distribution and Cancer Potential of Colonic Polyps. Ann. Surg.190, 679-683, 1979.
  pubmed

• 6) 小西文雄, Morson, B. C.:内視鏡的に別除された大腸腺腫および早期浸潤癌の臨床病理学的研究-St. Mark's Hospital における症例の検討-大腸肛門誌 35, 103-111, 1982.

• 7) 武藤徹一郎, 上谷潤二郎, 沢田俊夫・他:大腸ポリープと早期癌.臨床科学 19, 131-138, 1983.

• 8) 武藤徹一郎, 上谷潤二郎, 沢田俊夫・他:大腸ポリープ周囲粘膜に認められる白斑の臨床病理学的研究-とくに早期癌との関連性について-日本消化器内視鏡学会誌 23, 241-247, 1981.

• 9) 横山善文, 佐々木喬敏, 丸山雅一:(大腸早期癌の診断) 大腸ファイバースコープによる診断.日本臨床39, 2083-2090, 1981.

• 10) Fenoglio, C. M., Kaye, Ge I. and Lane, N.:Distribution of human colonic lymphatics in normal, hyperplastic and adenomatous tissue. Gastroenterology.64, 51-66, 1973.

• 11) Shatney, C. H.:Management of focally malignant pedunculated adenomatous colorectal polyps. Dis. Col & Rect.19, 334-341, 1976.

• 12) Morson, B. C., Bussey, H. J. and Samoorian, S.:Policy of local excision for early cancer of the colorectum. Gut.18, 1045-1050, 1977.
  pubmed

• 13) Lock, M. R., Cairns, D. W. and Ritchie, J. K.:The treatment of early colorectal cancer by local excision. Brit. J. Surg.65, 346-349, 1978.
  pubmed

• 14) 上谷潤二郎, 武藤徹一郎:ポリペクトミーの適応と手術を要する場合. Medicina. 20, 2326-2328, 1983.

• 15) 武藤徹一郎:「大腸sm癌」アンケート集計報告とその考察.胃と腸 18, 851-855, 1983.

• 16) 上谷潤二郎, 武藤徹一郎, 小西文雄一他:大腸癌および大腸腺腫摘除後患者の定期的追跡調査(surveillance). 大腸肛門誌 37, 145-149, 1984.

• 17) 柳沢昭夫, 加藤 洋, 菅野晴夫:前癌病変としての大腸腺腫.臨床成人病 12, 1889-1895, 1981.

• 18) 広田映五, 板橋正幸, 原田守久・他:大腸癌診断治療の最新の進歩-大腸癌の病理-. へるす出版 東京, p.315-326, 1982.

• 19) Gilbertsen, V. A.:Proctosigmoidscopy and polypectomy in reduction the incidence of rectal cancer. Cancer.34, 936-939, 1974.

P.203 掲載の参考文献

• 1) 幕内雅敏, 長谷川 博, 山崎 晋, 万代恭嗣, 渡辺五朗, 伊藤 徹:肝細胞癌の早期診断方法.I.超音波検査, 309-328頁, 服部 信編著.ウイルス肝炎から肝細胞癌へ.癌と化学療法社, 1982.

• 2) Holm, H. H. and Kristensen, J. K.:Ultrasonically Guided Puncture Technique, Copenhagen, Munksgaard.1980.

• 3) 松井 修, 高島 力:肝癌の血管造影診断, 133-141頁, 内科Mook, No.18, 東京, 金原出版, 1982.

• 4) Okuda, K.:Demonstration of growing chots of hepatocellular carcinoma in the portal vein by celiac angiography. The thread and streaks sign. Radiology.17, 303-309, 1975.

P.209 掲載の参考文献

• 1) 日本膵臓病研究会編:膵癌取扱い規約, 金原出版, 1982.

• 2) 日本膵臓病研究会, 膵癌登録小委員会:膵癌治療の現況-膵癌全国登録症例の分析から. 胆と膵 4, 997, 1983.

• 3) Moossa, A. R.:Tumors of the pancreas, Williams & Wilkins, 1980.

• 4) Ariyama, J., Shirakabe, H., Ikenobe, H et al.:The diagnosis of the small resectable pancreatic carcinoma, Clin. Radiol.28, 437, 1977.
  pubmed

• 5) 林 敏, 建部高明, 石井兼央・他:膵癌における血清 CA19-9 の診断的意義, 日膵研プロシーディングス, 14(1), 8, 1984.

• 6) 内藤厚司, 鈴木 敞, 戸部隆吉:膵癌と腫瘍マーカー, 特に血清糖鎖抗原 (CA19-9) を中心として, 日膵研プロシーデイングス, 14(1), 8, 1984.

• 7) 炭田正孝, 有山 襄, 白壁彦夫・他:2cm以下の小膵癌の診断と病理-膵内限局型癌について, 胆と膵 4, 1051, 1983.

• 8) 高木国夫, 竹腰隆男, 加藤 洋・他:膵癌診断の現況-小膵癌発見のために-.胃と腸 15, 595, 1980.

P.216 掲載の参考文献

• 1) 中山恒明, 鍋谷欣市,,牧野耕治・他:食道癌-特に胸部上中部食道癌について-. 外科診療 7, 682-687, 1965.

• 2) 葛西森夫, 渡辺登志男, 阿保七三郎・他:胸部食道癌に対する-期的根治手術の適応限界について. 外科 31, 1362-1367, 1969.

• 3) 阿保七三郎, 渡辺登志男:一期的食道再建術の適応設定による食道癌手術成績の向上. 外科治療 25, 250-255, 1971.

• 4) 葛西森夫, 渡辺登志男:術前の全身状態からみた食道癌の治療方針-特に胸部上中部食道癌について-. 外科診療 15, 784-789, 1973.

• 5) 都築俊治, 掛川暉夫, 中山隆市・他:食道癌の一期的手術と分割手術の適応と成績外科 33, 1044-1050, 1971.

• 6) 榊原 宣, 小林誠一郎, 御子柴幸男・他:食道癌手術の根治性とRisk. 手術 26, 919-927, 1972.

• 7) 杉町圭蔵, 中村輝久, 三戸康郎・他:われわれのリスク点数法からみた食道癌術後合併症の検討-とくに安全手術の限界について-. 外科治療 32, 575-579, 1975.

• 8) 佐藤 博, 磯野可一:食道癌の治療. 外科診療 17, 581-586, 1975.

• 9) 木下祐宏, 中山恒明, 遠藤光夫・他:食道癌手術と合併療法. 外科診療 17, 587-594, 1975.

• 10) 中山恒明, 吉田 充, 柳沢文憲・他:消化器癌に対する術前照射について-特に食道癌並びに胃癌の理論的根拠-. 日本外科学会雑誌 61, 1082-1083, 1960.

• 11) 後藤忠司:食道癌術前照射に関する臨床的並びに病理組織学的研究. 日本外科学会雑誌 67, 2094-2111, 1967.

• 12) 立花孝史:胸部食道癌の淋巴節転移に関する臨床的並びに病理組織学的研究. 日本外科学会雑誌 72, 891-963, 1971.

• 13) 平山 克, 西平哲郎, 葛西森夫・他:胸部食道癌姑息切除例の検討. 日消外会誌 16, 818-824, 1983.

P.229 掲載の参考文献

• 1) 芝 茂:手術と制癌剤の併用. 癌の臨床 14, 200-208, 1968.

• 2) 芝 茂, 田口鐵男:手術と抗癌剤併用の意義治療 56, 903-908, 1974.

• 3) 服部孝雄, 伊藤一二, 平田克治・他:マイトマイシンの術中大量投与-胃癌姑息切除時における理論と成績. 癌の臨床 10, 96-105, 1964.

• 4) 服部孝雄, 伊藤一二, 平田克治・他:胃癌の術中マイトマイシン大量投与法併用について. 姑息切除術における術後生存率を中心にして. 癌の臨床 11, 817-826, 1965.

• 5) 服部孝雄, 森 彬, 平田克治・他:胃癌の術中マイトマイシン大量投与の遠隔成績.癌の臨床 19, 241-248, 1973.

• 6) Imanaga, H. and Nakazato, H.:Results of surgery for gastric cancer and effect of adiuvant mitomycin-C on cancer recurrence. World J. Surg.1, 213-221, 1977.

• 7) 近藤達平, 井口 潔, 服部孝雄・他:胃癌に対するマイトマイシンC, フトラフール併用術後化学療法の効果に関する研究第5報, 5年生存率について. 癌と化学療法 9, 2016-2024, 1982.

• 8) 阿部令彦, 井口 潔, 服部孝雄・他:胃癌に対するマイトマイシンC, フトラフール術後長期化学療法の効果に関する研究. 第2次研究, 第2報癌と化学療法 10, 2408-2417, 1983.

• 9) 新本 稔, 服部孝雄, 伊藤一二・他:胃がん術後の補助免疫化学療法におけるLevamisoleの効果. 第1報.癌と化学療法9, 2133-2147, 1982.

• 10) Longmire, W. P. et al.:The use of triethylenethiophosphamide as an adjuvant to the surgical treatment of gastric and colorectal carcinoma. Ten year follow up. Ann. Surg.167, 293-312, 1968.

• 11) Carter, S. K and Comis, R. L:Gastric cancer;current status of treatment. J. Natl. Cancer Inst.58, 567-578, 1977.
  pubmed

P.238 掲載の参考文献

• 1) Jagelman, D. G. and Turnbull Jr, R. B.:Colectomy for malignant disease, in"Operative Surgery", p.106-113, Butterworths, London, 1977.

• 2) Goligher, J. C.:Surgery of the Anus, Rectum and Colon, 4th ed. p.453-455, Bailliere Tindall, London.1980.

• 3) Turnbull, R. B. et al.:Cancer of the colon":the influence of the no touch isolation technique on survival rates Ann. Surg.166, 420-427, 1967.

• 4) Goligher, J. C.:Surgery of the Anus, Rectum and Colon 4th ed. p.456-460, Bailliere Tindall, London.1980.

• 5) American Joint Committee.:Manual for staging of cancer, p.73-80, 1983.

• 6) Stearns Jr, M. W.:Neoplasms of the colon, Rectum and Anus p.89, John Wiley & Sons, New York, 1980.

• 7) Goligher, J. C.:Surgery of the Anus, Rectum and Colon. 4th ed. p.520, Bailliere Tindall, London, 1980.

• 8) Stearns Jr, M. W. and Deddish, M. R.:Five year results of abdomino-pelvic lymph node dissection for carcinoma of the rectum Dis. Colon Rect.2, 169-172, 1959.

• 9) Sauer, I. and Bacon, H. E.:A new approach for excision of carcinoma of the lower portion of the rectum and anal canal. Surg. Gynec. Obstet.95, 229-241, 1952.
  pubmed

• 10) 久留 勝:直腸癌. 日本外科学会雑誌, 41, 832-877, 1940.

• 11) Stearns Jr, M. W.and Schottenfeld, D.:Techniques for the Surgical management of colon cancer, Cancer.28, 165-169, 1971.

• 12) Stearns Jr, M. W.:The choice among anterior resection, the pull-through and abdomino-perineal resection of the rectum, Cancer.34, 969-971, 1974.

P.246 掲載の参考文献

• 1) 日本肝癌研究会:第5回原発性肝癌追跡調査報告(1978-1979年), 1982.

• 2) Tobe, T.:Current Status of Surgical Therapy for Primary Liver Cancer in Japan. Japanese Journal of Surgery.13, 86-89, 1983.
  pubmed

• 3) Tang Zhao You:Diagnosis and Treatment of Primary Hepatocellular Carcinoma in Early Stage. Report of 134 Cases. Chinese Medical Journal.92, 801-806, 1979.

• 4) Tang Zhao You:Treatment of Primary Liver Cancer-With Special Reference to the East Part of China. Annals Academy of Medicine.9, 251-255, 1980.

• 5) Thompson, H. H., Tompkins, R, K. and Longmire, W. P.:Major Hepatic Resection-A 25 Year Experience. Ann. Surg.197, 375-388, 1983.
  pubmed

• 6) Makuuchi, M., Hasegawa, H. and Yamazaki, S.:Intaoperative Ultrasonic Examination for Hepatectomy. Jpn. J. Chir. Oncol.11, 367-390, 1981.

• 7) Child, G. C.(ed.) :Portal Hypertension. Philadelphia, London, Toronto, W. B. Saundeis Co. p.82, 1974.

• 8) 水本龍二, 野口孝:手術の為の肝機能予備力の把握.戸部隆吉編集, 外科 Mook, 肝癌・胆道癌,p.41-47, 金原出版 K.K., 1983.

• 9) Tobe, T.:Hepatectomy in Patients with Cirrhotic Liver. Clinical and Basic Observations. Surgery Annul, in press.

• 10) 日本肝癌研究会:第6回原発性肝癌調査報告(1980-1981年), 1984.

• 11) Eiseman, B., Beart, R. and Norton, L.:Multiple Organ Failure. Surg. Gun. Obst.144, 323-326, 1977.

• 12) 小澤和恵, 田中純次, 山本正之, 上山奉男, 戸部隆吉:肝切除後の術後管理.戸部隆吉編集, 外科 Mook, No, 31, 肝癌・胆道癌, 金原出版 K.K., p.113-122, 1983.

P.253 掲載の参考文献

• 1) Van Heerden, J. A., ReMine, W. H., Weiland, L H. and Mcllrath, D. C.:Total pancreatectomy for ductal adenocarcinoma of the pancreas. The Mayo Clinic experience. Am. J. Surg. 142, 308, 1981.

• 2) Warren, K. W., Christophi, C., Armendariz, R. and Basu, S.:Current trends in the diagnosis and treatment of carcinoma of the pancreas. Am. J. Surg.145, 813, 1983.
  pubmed

• 3) Levin, B., ReMine, W. H., Hermann, R. E, Scheive, P. S. and Cohn, I Jr.:Panel;Cancer of the pancreas. Am. J. Surg.135, 185, 1978.

• 4) 松野正紀, 佐藤寿雄:術後遠隔成績からみた膵癌治療の問題点.日外会誌 83, 1051, 1982.

• 5) 宮崎逸夫, 永川宅和:膵癌の拡大根治手術, 胆と膵 1, 441, 1980.

• 6) 二村雄次, 鈴木雄彦, 早川直和, 松本隆利・他:膵頭部癌に対する外科治療上の問題点-主に膵癌の神経叢浸潤と膵全摘術の意義について-. 日外会誌 83, 1055, 1982.

• 7) Fortner, J. G.:Regional resection of cancer of the pancreas. A new surgical approach. Surgery. 73, 307, 1973.
  pubmed

• 8) 尾形佳郎, 恒元 博:膵癌外科治療の問題点-膵癌切除に於ける血管合併切除の意義と速中性子線治療の試み-.日外会誌 83, 1043, 1982.

• 9) 高田忠敬, 羽生富士夫, 中村光司, 福島靖彦-他:膵癌に対する拡大手術の検討-主要血管合併切除. Appleby 手術, 膵全摘を中心に-.日外会誌 83, 122, 1982.

• 10) 鈴木 敞:膵癌の診断および切除成績向上にむけての私どもの試み. 日消外会誌 16, 1001, 1983.

• 11) 高木国夫, 太田博俊, 大橋一郎・他:ERCPによる膵癌の診断能とその限界. 胃と腸 17, 1065, 1982.

• 12) 小寺太郎, 松野正紀, 小針雅男, 山内英生・他:小膵癌とその外科治療. 胆と膵 4, 25, 1983.

• 13) 佐藤寿雄, 松野正紀, 山内英生, 宮川菊雄・他:膵癌の治療法の問題点. 肝胆膵 4, 547, 1982.

• 14) Goldson, A. L:Techniques and indications for intraoperative radiotherapy of pancreatic carcinoma. Pancreatic Cancer. Cohn, 1. Ed., Masson Publ. USA Inc. New York, pp.22, 1981.

III 消化器がんの予防

P.260 掲載の参考文献

• 1) Ross, A. H. M., Smith, M. A., Anderson, J. R. and Small, W. P.:Late mortality after surgery for peptic ulcer. N. Engl. J. Med.307, 519-522, 1982.

• 2) Kumashiro, R., Inokuchi, K., Tokudome, S., Ikeda, M. et al.:Mortality of carcinoma after partial gastrectomy. Gann, 75(7), 588-594, 1984.

• 3) Domellof, L. and Janunger, K-G.:The risk for gastric carcinoma after partial gastrectomy, Am. J. Surg.134, 581-584, 1977.
  pubmed

• 4) Helsinger, N. and Hillestad, L.:Cancer development in the gastric stump after partial gastrectomy for ulcer. Ann. Surg.143, 173-179, 1956.

• 5) Krause, U.:Late prognosis after partial gastrectomy for ulcer, A follow-up study of 361 patients operated upon from 1905 to 1933. Acta. Chir. Scand.114, 341-354, 1958.
  pubmed

• 6) Hirohata, T.:Mortality from gastric cancer and other causes after medical or surgical treatment for gastric ulcer. J. Natl. Cancer Inst.41, 895-908, 1968.
  pubmed

• 7) Ihre, B. J. E., Barr, H. and Havermark, G.:Ulcer-cancer of the stomach:A follow-up study of 473 cases of gastric ulcer, Gastroenterologia.102, 78-91, 1964.

• 8) Tokudome, S., Kono, S., Ikeda, M., Kuratsune, M., Sano, C., Inokuchi, K. et al.:A prospective study on primary gastric stump cancer following partial gastrectomy for benign gastroduodenal diseases. Cancer Research, in press.

• 9) 吉川邦生:胃がん高危険群に関する研究, 特に職域集検の立場から. 昭和52年度厚生省がん研究助成金による研究報告集(下), 443-445, 国立がんセンター, 1978.

• 10) Sano, C., Kumashiro, R., Saito, T. and Inokuchi, K.:Promoting effect of partial gastrectomy on carcinogenesis in the remnant stomach of rats after oral administration of MNNG, Oncology. 41, 124-128, 1984.
  pubmed

• 11) Wynder, E. L. and Reddy, B. S.:Diet and cancer of the colon. Current concepts in Nutr.6, 55-71, 1977.

• 12) Mastromarino, A., Bandaru, S., Reddy, D. V. M. and Wynder, E. L.:Metabolic epidemiology of colon cancer:enzymic activity of fecal flora. Am. J. Clin. Nutr.29, 1455-1460, 1976.

• 13) Bariello, S. P., Draser, B. S., Tomkins, A. and Hill, M. J.:Relative carriage rates of nuclear dehydrogenating clostridia in two populations of different colorectal cancer risk. J. Clin. Pathol 36, 93-95, 1983.

• 14) 貝原信明:大腸がんおよび残胃がん発生における胆汁酸の意義に関する研究. 日本消化器外科学会雑誌 17, 537-546, 1984.

P.271 掲載の参考文献

• 1) Prevention of primary liver cancer:Report on a meeting of a WHO scientific group. Lancet 1, 463-465, 1983.
  pubmed

• 2) Prevention of liver cancer. Technical Report series No.691, WHO, Geneve, 1983.

• 3) Amano, S and Yamamoto, H.:Infectious hepatitis and cirrhosis as its sequela in Japan. Pathological Investigation. Ann. Rep. Institute for Virus Research, Kyoto University, 3, pp.185-334, 1960.

• 4) 肝炎-特集-, 治療学 11,(5) 1983.

• 5) 肝炎ウイルスマーカー測定法とその意義.肝胆膵 8(1), 1984.

• 6) 吉沢浩司:ウイルス肝炎, 中外医学社, 1984.

• 7) 西岡久壽彌:肝炎ウイルスと肝癌. Ongologia 4, 76-91, 1983.

• 8) Shikata, T. et al.:Staining methods of Australia antigen in paraffin section. Japan. J. exp.Med., 44, 25-36, 1974.

• 9) Blumberg, B. S., Alter, H. J. and Visnich, S.:A new antigen in Ieukemia sera. J.A.M.A.19, 541.

• 10) Okochi, K. and Murakami:Observations on Australia antigen in Japanese. Vox. Sarg.15, 374-385, 1968.

• 11) Blumberg, B. S., London, W. T.:Hepatitis B virus and and the prevention of primary hepatocellular carcinoma. New Engl. J. Med., 304, 782-784, 1981.
  pubmed

• 12) Nishioka, K., Mayumi, M., Okochi, K. et al.:Natural history of Australia antigen and hepatocellular carcinoma. Analy Fical and Experimental Epidemiology of Cancer(ed. by Nakahara, W.et al.) University Park Press, pp.137-146, 1973.

• 13) Ohbayashi, A., Okochi, K. and Mayumi, M.:Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology 62, 618-625, 1972.
  pubmed

• 14) Obata, H., Hayashi, N., Motoike, Y. et al.:A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int. J. Cancer 25, 741-747, 1980.
  pubmed

• 15) Sakuma, K. et al.:Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests. A prospective study, Gastroenterology 83, 114-117, 1982.
  pubmed

• 16) Okada, K., Yamada, Y., Miyakawa, Y. et al.:Hepatitis B surface antigen in the serum ofinfants after delivery from asymptomatic carrier mothers. J. Pediatr.87, 360-363, 1975.

• 17) Okada, K., Kamiyama, I., Inomata, M. et al.:e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants, N. Engl. J. Med.294, 746-749, 1976.

• 18) Takahashi, K., Akahane, Y., Gotanda, T. et alet al.:Demonstration of hepatitis B e antigen in the core of Dane particles. J. Immunol 122, 275-279, 1979.

• 19) Shikata, T., Karasawa, T., Abe, K., Uzawa, T., Suzuki, H., Oda, T., Imai, M., Mayumi, M.and Moritsugu, T.:Hepatitis-B e antigen and infectivity of hepatitis-B virus. J. Infect. Dis.136, 571-576, 1977.

• 20) Szmuness, W., Stevens, C. E., Harley, E. J. et al.:Hepatitis B vaccine, Demonstration efficacy in a controlled trial in a high-risk population in the United States. New England J.Med.303, 833-841, 1983.

• 21) Tada, H., Yanagida, M., Mishima, J. et al.:Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics 70, 613-619, 1982.

• 22) 厚生省肝炎研究連絡協議会, 昭和57年度研究報告, B型肝炎研究班および予防研究班 pp.67-108, 109-146, 1983.

• 23) Kan, L Y., Yuan, G. J., Yu, C. Z. et al.:Interruption of mother to infant transmition of HBV. Chinese Journal of Infectious Diseases(in Chinese) 1, 187-191, 1983.

• 24) Beasley, R. P., Hwang, L. Y., Lee, G.C.Y. et al:Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immunoglobulin and hepatitis B vaccine. Lancet 2, 1099-1102, 1983.

• 25) Wong, V.C.W., Ip, H.M.H., Reeshik, H.W. et al.:Prevention of the HBs Ag carrier statein newborn infants of mothers who are chronic carrier of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Double-blind randomized placebo-controlled study. Lancet 1, 921-926, 1984.

• 26) 西岡久壽彌:肝炎ウイルス感染症の現況. 公衆衛生47, 207-212, 1983.

• 27) Hill, A. B.:The environment and disease. Association or causation? Proc. Roy. Soc. Med.58, 295-300, 1965.

• 28) Arthur, MJ.P., Hall, A.J., and Wright, R.:Hepatitis B, hepatocellular carcinoma and strategies for prevention. Lancet 1, 607-610, 1984.

P.280 掲載の参考文献

• 1) 厚生省公衆衛生局栄養課監訳, がん予防と食生活-全米科学アカデミー「食物, 栄養とがん」に関する特別委員会報告-日本栄養食品協会, 東京, 1983.

• 2) Hisamichi, S., Yamagata, S., Sugawara, N. et al.:The Worldwide Survey on Fight Against Cancer, News Letter, Vol. 5, No.2, Eizai Co. Ltd., Tokyo, 1981.

• 3) WHO, Cancer Incidence in Five Continents, Vol. IV, Eds, Waterhous, J. et al., IARC, Lyon, 1982.

• 4) Hisamichi, S., Sasaki, R., Sugawara, N. et al.:Stomach Cancer in Various Age Groups(Japan) as detected by Gastric Mass Survey. J. Amer. Geriatrics Society.27(10), 439-443, 1979.

• 5) 市川平三郎:国際的にみた胃集検の実態と動向. 胃集検 39, 76-77, 1978.

• 6) Proceedings, 13th International Cancer Congress, Sep.8-15, 1982. Seattle, Washington, USA.

• 7) Cancer detection and prevention, Ed. Maltoni, E. C., International Congress Series No.322, Excerpta Medica, Amsterdam, 1974.

• 8) Recent advancer in cancer control, Eds. Yamagata, S. et al. International Series No.622, Excerpta Medica, Amsterdam, 1983.

• 9) 有末太郎, 山田由美子, 手林明雄・他:他臓器癌の集検との比較からみた胃集検の評価 日消集検誌 58, 53-60, 1983.

• 10) 飯沼 武, 館野之男, 橋詰雅・他:胃集検の利益と損失, I.救命と危険.日医放会誌 37, 1109-1121, 1977.

• 11) 久道 茂, 粟冠正利, 笹野伸昭・他:胃集検被曝集団の白血病および悪性腫瘍の誘発に関する調査研究(その1). 胃集検 56, 103-104, 1982.

• 12) WHO Technical Report Series 689, A Rational Approach to Radiodiagnostic Investigations, WHO, Geneva, pp.38, 1983.

• 13) Fruhmorgen, P. and Demling, L.:Early detectioll of the colorectal carcinoma with a modified Guaiac-test-A screening examination in 6,000 humans.胃集検 42, 43, 18-22, 1979.

• 14) ACS Report on The Cancer-Related Health Checkup, Approved by Board of Directors on February 8, 1980, American Cancer Society, Inc. USA, 1980.

• 15) 太田 恵, 深尾 彰, 菅原伸之:肝, 胆, 膵におけるエコー集検. 日消集検誌 57, 91, 1982.

• 16) Sackett, D.:Periodic examination of patients at risk. In:Cancer Epidemiology and Prevention, edited by D. Schottenfeld, Charles C Thomas, Springfield, pp.437-456, 1975.

• 17) Shapiro, S., Strax, P. and Venet, L.:Periodic breast cancer screening in reducing mortality from breast cancer. LAMA.215, 1777-1785, 1971.

• 18) Fontana, R. S., Sanderson, D. R., Woolner, L B. et al.:The Mayo Lung Project for early detection and localization of bronchogenic carcinoma. Chest.67, 511-522, 1975.
  pubmed

• 19) Cole, P. and Morrison, A. S.:Basic issues in population screening for cancer. J. Natl. Cancer Inst.64, 1263-1272, 1980.
  pubmed

• 20) 久道 茂, 白根昭男, 菅原伸之・他:早期胃癌の変貌.胃と腸 16, 71-77, 1981.

• 21) Eddy, D. M.:Finding cancer in asymptomatic people, estimating the benefits, costs and risks. Cancer.51, 2440-2445, 1983.
  pubmed

• 22) UICC Technical Report Series, Vol.40, Screening in Cancer, edited by A. B. Miller, UICC, Geneva, pp.338, 1978.